A Pumilio Domain That Forms Heritable Amyloid Aggregates in Yeast Can Regulate Pumillio-Mediated Translational Repression in Drosophila by Salazar, Anna Maria
A Pumilio Domain that Forms Heritable Amyloid Aggregates in
Yeast Can Regulate Pumillio-Mediated Translational
Repression in Drosophila
Thesis by
Anna Maria Salazar
In Partial Fulfillment of the Requirements
For the Degree of
Doctor of Philosophy
in Biology
California Institute of Technology
Pasadena, California
2008
(Defended September 24, 2007)
ii
©2008
Anna Maria Salazar
All Rights Reserved
iii
 Acknowledgements
I would like to thank my thesis advisor, Dr. Kai Zinn, for a multitude of
intellectual conversations, his willingness to allow me to pursue the difficult
scientific questions that I found to be incredibly intriguing, and for being a
generally kind individual and great lab mate; my thesis committee:  Dr. Bruce
Hay, Dr. Gilles Laurent, Dr. Angela Stathopolous, and Dr. Kai Zinn for their
support and time; Dr. Kaushiki Menon for numerous scientific conversations and
advice on numerous aspects of this project, in addition to her friendship; Viola
Nesterova for all the help that she has given me through the years and for a very
nice friendship; Elena Armand for everything that she did in lab to assist me and
for her constant amiable nature; Dr. Nina Tang-Sherwood for her amazing
friendship, her too-numerous-to-mention kind acts over the years and for being
an all-around amazing person; Ashley Wright for her friendship and constant
support and intellectual conversations; all the amazing friends that I have made
on campus, especially Dan Gold, Ben Rubin Johannes Grauman, and Juanse
Ramirez-Lugo; Lisa Nesterova for being a fabulous assistant throughout the
years and a good friend; Dasha Goloub for all of her help in lab and her
friendship;  Nicki Fox for her advice, constant support, and friendship; Alice
Schmid for interesting conversations and for her political fervor; all members of
the Zinn lab past and present who have been fabulous friends and have made
lab scientifically interesting and fun; all of the administrative and supporting staff
iv
at Caltech, who truly make Caltech a great place to be: Liz Ayala, Gwen
Murdock, Sam Westscott, Janie Malone, and Mary Alvarez; my friends on the
gardening, custodial, and plumbing staff who work so hard yet are rarely
recognized for their efforts, especially Walter Estrada, Patricia Estrada, and Erick
Flores who took me into their home as a member of their family when I first came
to Caltech as an undergraduate; Rosetta Pillow and Carmen for all of their hard
work when we were in the basement of BBB and for their kindness, thereafter.
       I would especially like to thank my family for all of their support,
especially my mom, who has always given so much to me over the years and
never expected anything in return.  Finally, I would like to thank Sean Brennan
for creating the music that helped me get through many long nights in lab, for
being my best friend, and for constant support.
vABSTRACT
Numerous human diseases have been described in which defects in protein
folding pathways play a role in the development of a disease state.  A subset of
these diseases result in a decrease in the level of the active, native conformation
of the protein.  This could arise from several mechanisms, including an increase
in degradation caused by misfolding, alterations in trafficking of the misfolded
protein, or aggregation of the protein with a consequent decrease in the soluble,
active form of the protein.  At least 40 human diseases that fit into this last
category, and are associated with the formation of amyloid fibers, deposits, or
inclusions, have been characterized.  Domains rich in glutamine (Q) and
asparagine (N) are one class of sequences that seem to possess an affinity to
form amyloids under native conditions.  These domains are present in many
metazoan proteins, including 472 in Drosophila and 143 in C. elegans.  Q/N
domains are found in several yeast prions.  It is hypothesized that these domains
may have been positively selected during evolution, perhaps in order to allow
reversible switching of the functional domain of the protein into an inactive
aggregated state.  We wondered if this type of selection might also maintain Q/N
domains in metazoans. The Drosophila melanogaster and Caenorhabditis
elegans proteomes were searched for predicted proteins that contain nucleic acid
binding domains (for RNA, DNA or both), and Q/N-rich sequences, using a
threshold of 30 Q/Ns in 80 residues.  One of the two strong Drosophila
vi
candidates is the translational repressor Pumilio (Pum).  Earlier work by our
group (Menon et al., Neuron 44, 663-676 (2004)) had shown that Pum is
localized to the postsynaptic side of the larval neuromuscular junction (NMJ),
where it acts as a regulator of local mRNA translation.  In pum mutants, synaptic
morphology is altered and GluRIIa is dramatically upregulated.  This study shows
that a Q/N-rich domain (denoted NQ1) from Pum is able to form ordered
aggregates in budding yeast and is able to recapitulate the activity of a yeast
prion, New1p: including visible aggregates, heritable phenotypic switching, and
reversibility of an induced yeast prion state, [Psi+], by guanidine hydrochloride.
To test whether NQ1 aggregate formation can perturb Pum's function in the
nervous system, transgenic fly lines in which NQ1 expression is driven by GAL4
were created.  Postsynaptic NQ1 expression generates alterations in the NMJ
that phenocopy the pum loss-of-function phenotype and interact genetically with
pum mutations. This is observed through an increase in type 1s and type 1b
boutons and an increase in GluRIIa at the NMJ.  Postsynaptic Pum
overexpression in muscles is lethal, but co-overexpression of NQ1 partially
rescues this lethality, resulting in Drosophila that survive until eclosion.  Thus, in
both the wild-type and overexpression contexts, a domain that forms heritable
aggregates acts as a negative regulator of Pum activity.
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1Introduction
Numerous human diseases have been described in which defects in
protein folding pathways play a role in the development of a disease state.  A
subset of these diseases result in a decrease in the level of the active, native
conformation of the protein.  This could arise from several mechanisms, including
an increase in degradation caused by misfolding, alterations in trafficking of the
misfolded protein, or aggregation of the protein with a consequent decrease in
the soluble, active form of the protein.  At least 40 human diseases that fit into
this last category and are associated with the formation of amyloid fibers,
deposits, or inclusions, have been characterized (Dobson, 2006).  Huntington’s
Disease, Parkinson’s Disease, Alzheimer’s Disease, Spino-cerebrellar Ataxias,
Type II Diabetes, Injection-localized Amyloidosis, Lysozyme Amyloidosis, Spinal
and Bulbar Muscular Atrophy, and Spongiform Encephalopathies are some of
these diseases, and are caused by the aggregation of these different respective
proteins: Huntingtin with an expanded polyQ expansion, α-Synuclein, Amyloid-β,
Ataxins with a PolyQ expansion, Amylin, Insulin, Lysozyme, Androgen Receptor
with an expanded polyQ expansion, and Prion Protein (Dobson, 2006).  It is
evident from this subset of human diseases involving protein aggregates that the
types of diseases and the proteins that cause the diseases are quite variable.  In
addition, it is also apparent that some of these diseases are quite common, like
Alzheimer’s Disease, which affects approximately 14.4 million people in the world
(Ferri et al., 2005), or Type II Diabetes, with 150 million people affected
2worldwide, including 20% of the population of the United States over the age of
65 (Zimmet et al., 2001).  Understanding more about the causes of protein
folding diseases, therefore, is imperative.  In order to understand more about
these diseases, however, it is necessary to understand more about protein
folding and misfolding in general.
 Recent studies have suggested that ordered aggregates composed of β-
pleated sheets, such as amyloid fibers, can possibly form from many, and
perhaps even all, polypeptide chains in vitro (reviewed by Dobson, 2006).
Protein folding theories have proposed that it is the identity of the side chains of a
polypeptide sequence that determine how a protein will fold into its native form.
In keeping with this theory, several sequences have been identified that seem to
promote aggregation, including glutamine (Q) and asparagine (N) rich domains,
and specific short peptide repeats (Chiti et al., 1999; Lopez de la Paz et al.,
2002).
It has also been observed, however, that numerous sequences that have
not been known to form beta sheets or amyloid fibers in vivo are capable of doing
so in vitro, under appropriate conditions.  It has, therefore, been proposed that all
polypeptides have the capability of forming amyloid fibers under certain
conditions and that the formation of amyloid fibers is not dependent on
sequence.  For example, myoglobin, a protein whose native conformation is
composed of mostly alpha helices, can form beta-pleated sheets, and even
amyloid fibers in vitro (Fandrich et al., 2001).  Myoglobin is a 153 amino acid
316.7kD protein.  Its crystal structure, determined in 1958, was shown to be
comprised of mostly alpha helices.  Partially folded states that have been studied
have also revealed alpha helices, although there is some evidence for other
structures in the precipitated or aggregated form (Eliezer et al., 1998). There is
no evidence that myoglobin is capable of folding into a beta-sheet structure in
vivo, and myoglobin amyloid fibers have not been seen in any disease state.
However, it has now been shown that myoglobin can form amyloid fibers in vitro,
as assayed by electron microsopy (EM), thioflavin-T binding, and Congo red
birefringence (Fandrich et al. 2001).  These fibers also show a single circular
dichroism minimum at 215 nm (diagnostic of beta structure), and an X-ray
diffraction pattern that corresponds to beta structure.  The amyloid fibers formed
from apomyoglobin, (myoglobin lacking its haem group), were created under
conditions that destabilized the alpha-helix native state, including high pH and
65°C (Fandrich et al. 2001).
Other examples of proteins that have not previously been shown to be
associated with an amyloid disease, yet possess either a domain or an entire
protein sequence that is capable of forming amyloid fibers, have also been
published.   The SH3 domain of the p85α subunit of phophatidylinositol 3-kinase
is capable of forming amyloid fibers under acidic conditions in vitro (Guijarro et
al., 1998).  In addition, human muscle acylphosphatase, a small protein with both
alpha and beta secondary structure and consisting of 98 amino acids, has been
4shown to be capable of forming amyloid fibers under moderately denaturing
conditions that still allow the formation of hydrogen bonds (Chiti et al, 1999).
Furthermore, polyamino acids, or peptides that are composed of multiple
copies of one amino acid, are also capable of forming amyloid fibers under
specific in vitro conditions. For example, poly-L-lysine, poly-L-glutamic acid, and
poly-L-threonine form amyloid fibers that are visible under EM, bind Congo red,
bind thioflavin-T, reveal a 215 nm minimum as determined by CD, show a cross-
β structure when analyzed by X-ray diffraction, and display long-term amyloid
fiber stability at room temperature (Fandrich and Dobson, 2002).  Although the
group who conducted these experiments attempted to form amyloid fibers from
several other amino acids, the other poly amino acids precipitated too readily,
thereby preventing the ability to determine whether other polyamino acids could
form amyloid fibers as well (Fandrich and Dobson, 2002).  Previous studies,
however, have shown the ability of various other polyamino acids to form beta-
sheet aggregates in vitro (reviewed by Dobson 2006).  This data implies that the
character of the amino acid side chain is not a determinant of the capability of a
polypeptide to form an amyloid fiber in vitro.  In fact, it is proposed that it is the
polypeptide backbone itself that confers the ability to form crossed beta-sheets
and amyloid fibers.  The polypeptide backbones of these polyamino acids form
hydrogen bonds as they fold back onto themselves.  It is, therefore, theorized
that the generic conformational state of any peptide is an amyloid formed from
5cross beta sheets, and that the native, globular shape of the protein is conferred
by the side chains.
Although poly-L-glutamine expansions were one of the first poly amino
acid expansions shown to form amyloid fibers and to confer a disease state in
vivo because of such expansions, other diseases corresponding to expansions in
other amino acids have been discovered.  Pathological fibers formed from poly-L-
alanine, oculopharyngeal muscle dystrophy (Calado et al., 2000), or poly-L-
leucine, Huntington disease-like 2 (Margolis et al., 2001), expansions have also
been observed.  These examples provide more evidence that extended
expansions of amino acids other than glutamine may be capable of forming
amyloid fibers in vivo and may be responsible for other pathological states.
Contrary to accepted perceptions, therefore, it seems quite plausible that
any polypeptide can form amyloid fibers under the correct conditions.   The
amyloid and cross-beta-sheet formation, therefore, is a generic form of
polypeptides, requiring only the peptide backbone for hydrogen bonds and
stabilization.  The native, globular forms of proteins, therefore, are acquired
through the ability to form alpha helices and other structures that may be more
rapidly formed under physiological conditions, thereby disrupting the access of
the polypeptide backbone to hydrogen bond with itself and form cross-beta
sheets and amyloid fibers.  In addition, it is proposed that specific chaperones,
including heat shock receptors, are essential for preventing amyloid fiber
formation and promoting native globular protein folding.  Disulfide bond formation
6and specific residues, such as prolines, that disrupt the structure of the peptide
background, also contribute to the formation of the globular protein (Chiti and
Dobson, 2006).
 There have also been recent advances in the elucidation of the steps of
protein folding, an understanding of which is necessary for studying diseases
caused by protein aggregation.  There are numerous proteins in living organisms.
Humans are thought to possess over 100,000 different proteins.  However, this
number still represents an infinitesimally small subset of the total number of
sequences that could exist, given the average number of amino acids per protein
and the fact that 20 different amino acids make up these proteins. Thus, out of a
vast number of choices, a very small specific set of proteins have evolved and
been maintained in order to carry out specific tasks.  It is the specific sequence of
these proteins that encode the tertiary and quaternary structure of proteins that
allow them to carry out their required cellular function.  It is, therefore, fairly clear
that precise protein sequence and folding are important for the daily activity of all
organisms, and that these protein sequences have been targets of immense
evolutionary pressure in order to successfully maintain many of the numerous
complex functions of a cell.
In order for a cell to accomplish such a complex task as specifying precise
protein structure and folding, the sequence of a protein is essential.  Cells,
however, also require chaperone proteins to assist in the final attainment of
appropriate secondary and tertiary structure and to prevent incorrect states from
7being formed.  This is especially essential given the fact that most cells contain a
very high concentration of proteins and other molecules, estimated to be
between 300-400 mg/ml (Ellis RJ, et al, 2003).  In fact, it seems as though the
concentration of a particular protein in a cell corresponds well to being just below
the concentration under which the protein spontaneously starts to aggregate.  An
analysis was conducted on known in vitro aggregation rates for a group of 12
proteins that compared in vitro aggregation rate data with the expression-level
data obtained from microarray analysis.  A clear anti-correlation was observed,
with the proteins containing higher aggregation rates having lower expression
levels.  In fact the rates of the 12 proteins analyzed resulted in a correlation
coefficient of .97, quite remarkable (Tartaglia, et al, 2007).  This means that
evolution has not only created proteins with suitable amino acids sequences to
allow appropriate folding, but also the expression levels of each of these proteins
may have evolved to be just under the concentration at which that specific
protein will start to self-aggregate, given the rate of aggregation.  One item to
note is that when the protein Pmel17, a human protein involved in
premelanosome morphogenesis which is thought to be functional in the amyloid
state (Berson et al. 2001), is analyzed, it possesses a much higher aggregation
rate than would be expected from where it would fall on the graph, given its
expression level (Tartaglia, et al, 2007).  This means that it is expressed at a
concentration that is conducive to its aggregation, which makes sense because
the amyloid form may be required for its normal activity.
8Another study has provided more evidence for an evolutionary adaptation
against self-aggregation.  Given the observation that increases in the local
concentration of a protein can result in aggregation, experiments were conducted
on proteins that contained repeating domains to analyze whether these proteins
might promote aggregation between such domains.  At least two amyloid
diseases are caused by aggregates involving immunoglobulin domains (Selkoe,
2003).  Given the fact that numerous proteins contain tandem repeat domains,
and the fact that the immunoglobulin and fibronectin domains are two of the most
common tandem repeats, both were analyzed.  The 27th immunoglobulin domain
of human cardiac titin, which has not been implicated in an amyloid diseased
state, was first shown to be capable of forming amyloid fibers in vitro under
moderate denaturing conditions.  When peptides were created that contained
two, three, or eight repeats of this domain, an increase in the rate of fiber
formation was observed.  In fact, each of these peptides showed an approximate
10-fold increase in aggregation rate in comparison to the monomer itself.  Given
the lack of differences in the rates as long as the construct contained at least two
tandem repeats of the immunoglobulin domain, this result gives credence to the
concept that two interacting domains may be a key step in the formation of
amyloids, perhaps in the same manner that seeding increases the rate of
amyloid formation.  Furthermore, when constructs containing two immunoglobulin
domains that vary by more than 60-70% are created, no detectable increase in
aggregation rate is observed.  For constructs containing tandem domains with
9more than 70% similarity, however, rates of aggregation seem comparable to
using two tandem repeats with exact sequence homology.  When the fibronectin
and immunoglobulin superfamilies in the human genome are compared, only
10% of the proteins contain adjacent domains with greater than 40% sequence
identity.  This data may imply that sequence diversity between tandem domain
repeats in a protein have evolved to decrease the capacity to form intermolecular
aggregates that might lead to amyloid fiber formation.  This is also an example in
which sequence similarity seems to increase the ability to form amyloid fibers,
perhaps because the specific manner in which the side-chains are arrayed do
play an important role in the stability of an aggregate, in addition to the main
chain.  Although it may be the case that any protein can form amyloid fibers,
these observations may be one of the reasons why oligomers often seem to seed
the formation of amyloid aggregates that consist of the same protein as the seed
and the fact that amyloid aggregates most often consist of one dominant protein.
An amyloid fiber, therefore, may be stabilized by repeating residues, in a manner
similar to crystal structures (Wright, 2005).
Another interesting piece of data involving the study of amyloid formation
involves the Congo red binding assay.  It has recently been shown that Congo
red is not as specific for amyloid species as previously believed and as obvious
from the fact that most papers that reference a protein’s ability to form amyloid
fibers include data about Congo red binding and birefringence. It has long been
known that Congo red can bind to collagen fibers and cytoskeleton filaments and
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still exhibit yellow-green birefringence (Linder et al., 1979).  Congo red has been
shown to bind to proteins in their native conformation, regardless of the nature of
their secondary structure.  For example Congo red is capable of binding to the
native conformation of proteins as diverse as insulin (composed mostly of α
helices), lysozyme (α  and β), concavalin A (β), citrate synthase (α), interleukin-2
(α), malate dehydrogenase (α and β), beta-lactoglobulin, and apomyoglobin (α)
and exhibiting yellow-green birefringence (Khurana et al., 2001).  Because of this
lack of specificity, Congo red does not seem like the ideal diagnostic of amyloid
formation.  This is important because many papers claim Congo red binding and
birefringence as evidence for the amyloid structure, when this is not necessarily
the case.  Furthermore, thioflavin T is recommended as a better diagnostic tool,
as it seems more specific to amyloid fibers than Congo red (Khurana et al.,
2001).
Some sequences have a high propensity to form specific secondary
structures, such as alpha helices.  Other sequences are more prone to form β-
sheets.  Sequence information, therefore, is important for determining what type
of structure a protein may be more prone to form.  Even though all proteins may
be capable of forming amyloid structures in vitro, some sequences seem to be
more highly represented in proteins known to fold into amyloids in vivo, like Q/N
rich regions, but these regions are also common protein-protein interaction
domains. It has been posited that these Q/N regions interact fairly tightly with
other Q/N rich regions, perhaps forming a type of preliminary interaction to the
11
“zipper” structure deduced from NMR (Chiti and Dobson, 2006).  Furthermore,
the sequence of a protein determines its native globular state, so sequence is
extremely important. Numerous Q/N rich regions have been known to be
important in protein-protein interactions.  For example, the promoter specific
factor 1 (SP1), requires a Q rich region alternating with hydrophobic residues in
order to bind to dTAF110, a protein that is part of the TFIID complex that is
required for the recruitment of RNA polymerase and transcription (Gill et al.,
1994).  These Q/N rich regions may be important for protein-protein interaction,
which is supported by the presence of numerous proteins that contain these
regions at the synapse.  In fact, several proteins involved in translation contain
Q/N rich domains.
Stress granules have recently been colocalized with protein aggregates in
post-ischemic hippocampal CA1 neurons (DeGracia et al., 2007), and may
provide a possible expanation for the retention of Q/N rich domains in the
genome.  TIA-1 and TIAR are two related proteins that are involved in the
formation of stress granules.  Both of these proteins contain three N-terminus
RNA-binding domains and a C-terminus glutamine-rich motif termed the PRD
(prion-related domain) because of shared structural similarity to prion proteins.
In environmentally stressed cells, TIA-1 and TIAR are involved with removing
stalled initiation complexes to cytoplasmically localized foci termed stress
granules.  These sites are shown to contain mRNA, ribosome subunits, and RNA
binding proteins (RBP), and are hypothesized to be involved in sequestration of
12
mRNA and their ribonucleoprotein partners in times of stress prior to determining
whether an mRNA will be translated or degraded.  TIA-1 and TIAR have also
been proposed to play both a general role and to be directly involved in
translational repression (Mamczarz et al., 2006).  Under times of stress, TIA-1
and TIAR are hypothesized to interact with eukaryotic translation initiation factors
1 (eIF1), eIF3, and the 40S ribosomal subunit, instead of the eIF1, eIF2, eIF3,
eIF5, and 40S ribosomal subunit complex that normally associates with the 5’
end of capped mRNAs, thereby inhibiting protein translation (reviewed by Hocik
and Sonenberg, 2005).  Furthermore, TIAR and TIA-1 mediate the translational
repression of specific AU-rich element (ARE) mRNAs, including tumor necrosis
factor alpha 1 (TNFα), where cells that either lacked or contained TIA-1
contained the same level of mRNA, but differing levels of translated protein. The
ARE seems to confer a rapid degradation signal to mRNAs, which might be
related to translational repression (Piecyk et al., 2000).
Overexpression of full-length TIA-1 causes stress granule formation and
represses reporter gene expression.   In experiments where the PRD of TIA-1
was overexpressed, the PRD was shown to be capable of forming visible
cytoplasmic aggregates and sequestering endogenous TIA-1 and TIAR, thereby
reducing their ability to repress a reporter gene’s expression.  Removing the PRD
domain of TIA-1 perturbs stress granule formation and promotes mRNA
translation (Mamczarz, et al., 2006).   Furthermore, replacing the PRD with the
aggregate-forming prion domain of SUP35, the NM domain, results in normal
13
stress granule formation and repression of mRNAs (Gilks et al., 2004).
Furthermore, in neurons, fragile X mental retardation protein, FMR1, plays a
comparable role in the production of granules that seem to act in a similar
manner and possesses a similar structure.  FMR1 has also been co-localized
with Pum in stress granules (Vessey et al., 2006).  Furthermore, Q/N rich
proteins such as Pumilio 2, cytoplasmic polyadenylation element binding protein
(CPEB), and Poly A Binding Protein (PABP) have also been localized to stress
granules (reviewed by Kiebler and Bassel, 2006).  This is a very interesting
observation because (PABP) was also found in the database search for putatitive
prions that we conducted (see Chapter 1), the Aplysia version of the (CPEB) has
been implicated in possessing a prion-like activity (Si et al., 2003), and Pumilio is
discussed in this thesis.
The Q/N region of Pum may be important for various different functions,
such as interacting with protein partners in translational repression or binding to
proteins involved in stress granule formation and function. This study, however,
only investigates Pum’s possible propensity for aggregation, epigenetic
interaction with known prions, and epigenetic interaction with endogenous
Pumilio.
 .
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Chapter 1
A Pumilio Domain Can Form Heritable Ordered Aggregates in Yeast
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Chapter 1 Introduction
The Prion Hypothesis was first proposed by Stanley Prusiner to describe a
protein-only method of infectivity that was responsible for spongiform
encephalopathies.  Spongiform encephalopathies are diseases characterized by
a spongiform appearance in the brain.  Some of these diseases were genetic,
like Creutzfeld-Jacob Disease (CJD), or fatal familial insomnia (FFI), while others
seem to have been spontaneous.   Bovine Spongiform Encephalopathy (BSE), or
mad cow disease and other spontaneous forms of the disease derive from
consuming an infected organism, like the ritual cannibalism that led to Kuru,
another prion disase.  The prion protein, PrP, was eventually isolated and shown
to be a protein that was capable of epigenetic infectivity and the cause of the
diseased state (Prusiner, 1998).  Furthermore, endogenous PrP was shown to be
necessary for the ability of an organism to contract the disease.  This was shown
through studying mouse PrP knockouts, which were incapable of developing the
disease (Sailer, 1994).  This data implied that the disease state is caused by
something occurring with the endogenous protein, and not just some infective or
toxic agent.  A prion, therefore, would have to possess the ability to infect and the
ability to make use of a protein-only method of function, with a protein acting as
the genetic agent.
Prions are capable of catalyzing their own propagation in a process
whereby the protein serves as a seed or template in which the WT protein
becomes folded into the abnormal structure and aggregates.  This process has
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been observed in various organisms, including yeast, in which a model system
has been developed to increase the understanding of prion-like behavior
(reviewed by Wickner et al., 2004). Analyses comparing the amino acid
sequences of PrP, the protein responsible for the infectivity in transmissible
spongiform encephalophathies, and the recently identified yeast prions, reveal
motifs that may be involved in the aggregation and infectivity of these proteins.
PrP contains a short repeating motif, while the yeast prions seem to share an
enrichiment in glutamine/asparagine (Q/N) rich domains.  A subset of these
putative prions possessed oligopeptide domains that have recently been shown
to be necessary and sufficient for infection and maintenance of a prion-like state
in yeast (Osherovich, 2004).
Other Eukaryotic proteomes contain many Q/N rich blocks as well.  For
example, Weissman defined Q/N rich domains as those containing 30 Q/N
residues in 80 consecutive amino acids.  In S. cerevisiae, 107 polypeptides with
Q/N rich regions were identified, 143 were found in Caenorhabditis elegans, and
472 were found in Drosophila melanogaster (Michelitsch and Weissman, 2000).
Q/N rich domains are important in normal protein-protein interactions.  In fact, the
proteins that may be capable of epigenetic switches when overexpressed may
still require the Q/N rich domains for other normal functions.  Even so, retaining
such a high number of such sequences, given the putative beneficial effects of
prions in yeast, leads to immediate questions in higher organisms.  Do prion-like
activities of a subset of these proteins provide a positively functional, and hence
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evolutionarily conserved, activity?   In other words, might there exist some
function that has acted as a positive selection mechanism, thereby retaining
seemingly deleterious sequences within the genome?
The concept that all amyloid-forming proteins and, therefore, perhaps all
proteins, have the capacity to alter conformation upon seeding is relatively new.
Previously, it was believed that this was one of the fundamental characteristics of
prion proteins.  In fact, many of the original attributes associated with prions may
now be a general description of all proteins that are capable of forming amyloid
fibers. Prions were believed to be unique amongst proteins capable of
aggregating in that they are capable of not only seeding aggregates, but also are
able to replicate their form, are interconvertible with the WT form, and act in an
infectious manner (Prusiner, 1998).  It now seems as though any protein can
seed and replicate the amyloid form in vitro.  Some proteins may even be
considered interconvertible under specific conditions.  Other proposed prion traits
that no longer seem specific to prions are the observed prion strain differences in
various mammalian and yeast prions.
These strain differences were defined as different prion isolates that result
in different rates of infectivity and pathology when placed into a host (Prusiner,
1998).   When a host organism is inoculated with prions from a different species,
a species barrier that either precluded or decreased the propagation of the
infective protein in the host was sometimes observed.   The species difference
was also observed in yeast, where differences in the aggregation state, or normal
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activity of the protein were observed (reviewed by Harris and True, 2006).  These
species barriers could sometimes be caused by a protein derived from the same
amino acid sequence, but differ in the manner in which the prion was formed.
For example, when the amyloid-forming domains of a yeast prion, Sup35, were
purified and allowed to form aggregates in vitro at different temperatures, two
different [Psi+] phenotypes, the prion state derived from aggregated Sup35, were
observed when these amyloid fibers were introduced into yeast.  When the two
strains of Sup35 were analyzed, they were observed to possess differences in
the manner in which the subunits interacted with one another and in the length of
their amyloid core. (Tanaka et al., 2005).   Similar differences in structures
obtained from Amyloid β have also been observed, implying that other proteins
may be capable of different amyloid structures as well (Petkova et al., 2005).
This data makes sense given the possibility that amyloid formation is a generic
capability of all proteins involving the peptide backbone.  If this is the case, there
may be numerous manners in which an amyloid fiber can form.  Amyloid fibers
are stabilized by repeating domains, and once a fiber is seeded the rest of the
domains, comprising the fiber, may necessarily adopt the same structure as the
seed.
One of the most fundamental characteristic of a prion is its ability to infect.
This however, may also not be a quality that is unique to proteins previously
considered prions.   The prion hypothesis describes the protein-only manner of
infection by an altered conformation of PrP, PrP scrapie, which was capable of
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changing the endogenous PrP, a cell-surface glycoprotein, into the scrapie
version (Prusiner, 1998).  This was an infection without any nucleic acids and is
the fundamental quality of a prion.  In yeast, cells have been shown to replicate
and pass on the phenotype accompanying the aggregated form of yeast prions,
thereby “infecting” the budding yeast.  In addition, yeast can be inoculated and
transformed with amyloid fibers grown in vitro, which can elicit a prion state.
Although this shows that the amyloid fibers are capable of causing a prion state,
it does not show that this is actually an infection or that other amyloid fibers
cannot do the same thing.  It would be especially interesting to examine if
amyloid fibers from a protein like myoglobin could elicit a prion state when
transformed into yeast.
There is also evidence that shows that amyloid Aβ42 oligomers are
capable of “infecting” neurons in culture.  Aβ42 is the 42 amino acid peptide that
is formed from the proteolysis of APP.  It is known to be a major component of
amyloid plaques.  Low molecular weight oligomers, perhaps containing up to 12
copies of the Aβ42 protein, have been shown to be toxic.  Low molecular weight
oligomers of Aβ42 have been shown to be sufficient to decrease the number of
spines in hippocampal slices grown in the presence of the oligomer, block LTP,
and impair short term memory in rats injected with Aβ42 oligomers. Furthermore,
larger fibrillar aggregates of Aβ42 do not show similar changes and some of
these phenotypes can be specifically blocked by anti-oligomer antibodies, which
prevent the production of low molecular weight oligomers but do not bind to or
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break up larger Aβ42 fibers, implying that these effects are specific to the low
molecular weight oligomers (reviewed by Walsh and Selkoe, 2007).  This data
may imply that many of the disease-related states associated with Alzheimer’s
disease, especially loss of memory and morphological changes in the brain, are
actually caused by small oligomers of Aβ42 and not the large fibrillar aggregates
or amyloid plaques observed in autopsies.  It has been observed that small
oligomers of Aβ42 are capable of entering into neurons and causing the toxic
effects from within the neurons.  This also provides a gross example of protein
infectivity, in that a protein is able to cause a disease state within the cells that
the oligomers were not created within.  All of this could mean that Aβ42 is more
prion-like than previously believed, or it could mean that definitions of prions
need to be re-established.
A major question arises, however, as to what really should be considered
a prion and whether the yeast assays used really distinguish between prion-like
activity, or mere aggregation.  Recent evidence about the folding and misfolding
of proteins (reviewed by Dobson 2004; reviewed by Chiti and Dobson 2006), the
detailed mechanism about the action and activity of yeast prions (reviewed by
Wickner et al., 2004; Wickner et al., 2006), and the ability of other aggregation
prone proteins to act in a similar manner to putative yeast prions, might either
challenge the prion hypothesis regarding yeast prions, or at least make a prion
state a much more general protein ability than previously believed.
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There is now data that implies that some mammalian proteins as different
as insulin, poly Q proteins, and amyloid beta behave in a manner similar to well-
established yeast prions in assays that are similar to the ones that we have
conducted in yeast.  For example, Aβ42 can replace the N-terminus of Sup35
when an Aβ-Sup35EF chimera is used to replace the endogenous Sup35 in the
yeast genome (Bagriantsev and Liebman, 2006).  Low molecular weight amyloid
fibers derived from this chimera have been shown to be capable of inducing this
novel yeast strain into a “prion” state, in a manner comparable to the
endogenous function of the prion state of Sup35, [Psi+], which can be observed
by loss of nonsense repression of ADE1, resulting in white yeast colonies and
growth on –ADE plates.  This data, however, shows that this chimera possesses
a higher propensity to form aggregates, given the observation that no other prion,
such as a [pin+], is required to induce the formation of the Aβ-Sup35EF prion
state, [Aβ+]. In addition, Western blot analysis shows that mostly small oligomers
derive from this chimera, containing mostly dimers, trimers, and tetramers.  This
is interesting, in that although the prion state seems to be induced readily, larger
fibers are not created in vivo. Furthermore, mutations in Aβ42, which block
aggregate formation in vitro, decrease the ability of the chimera to form
aggregates and prevent the prion state from forming.  Interestingly, deletion of
Hsp 104 seemed to inhibit the formation of the oligomerization of Aβ-Sup35EF
(Bagriantsev and Liebman, 2006).  This seems unusual in that HSP 104 is known
to be required for maintenance of the prion state, with HSP 104 deletions
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normally resulting in a loss of the yeast prion state only because of a decrease of
an ability to break down larger aggregates into smaller, more soluble seeds that
could be passed on to daughter cells, not necessarily direct chaperone
assistance in the actual de novo formation of small oligomers from soluble
protein.
The importance of Q/N rich sequences on the ability of amyloids to initiate
a [Psi+] state in yeast has also been studied.  It has been observed that many of
the proteins studied thus far that are capable of expressing a prion-like behavior
in yeast seem to possess Q/N rich repeats.  This is the case for Sup35, New1,
Rnq1, Ure2, and several other proteins that are putative yeast prions.  In
addition, proteins that are not endogenous yeast prions are capable of acting in a
manner similar to yeast proteins if they contain polyQ or Q/N rich domains, such
as Huntingtin, or Machado Joseph’s disease (MJD) proteins.  These
observations have lead to the hypothesis that these Q/N regions are important
for the seeding of the [Psi+] state, and that the seeding occurs through an
interaction between these Q/N rich regions, which have already been shown to
be important protein interaction domains (Osherovich and Weissman, 2001;
Derkatch et al., 2004).  An alternative hypothesis posits that any aggregated
protein may titrate out essential chaperones that normally prevent misfolding,
such as Hsp104, and that no seeding takes place.
Experiments to address this question involved overexpressing aggregate
prone proteins that contained either poly Q/N regions or proteins, such as α-
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synuclein or synfilin-1, that aggregate but do not contain these regions. It has
previously been shown that the in vitro production of amyloid fibers can induce
the in vitro switch from a prion- state into a prion+ state in yeast (Brachmann et
al., 2005).  Proteins that contained either PolyQ or Q/N rich regions were much
more capable of both initiating a [Psi+] state in vivo and seeding the formation of
Sup35 fibers in vitro.  In vitro, however, Sup35 seeds were still much better at
seeding their own conversion into the aggregated state than any of the other
fibers tested.   In addition, both insulin and human Ig light chain were able to
significantly seed Sup35 aggregation in vitro (Derkatch et al., 2004).  This data
actually provides contrary evidence.  It shows that in vivo, sequences that
contain Q/N rich domains seem to be more capable of seeding Sup35
aggregates, but that various forms of amyloid fibers are capable of seeding
Sup35 amyloid formation in vitro, regardless of Q/N levels.  This data might imply
that although similar sequences might play a role in seeding, the general amyloid
form, regardless of sequence specificity, can seed the formation of other
amyloids, especially under in vitro conditions.
Yeast studies have also shown that these prions are quite widespread in
the genome, fairly conserved, and possibly functional.  In fact, some of these
yeast prions may be beneficial, which may explain the possible evolutionary
conservation of such sequences.  There is some controversy, however, about the
true beneficial effects of Sup35 or Ure2p.  A study that analyzed the native state
of numerous strain of yeast throughout the world did not find any in the [Psi+]
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state, even if the yeast resided in harsh yeast environments like high temperature
or high ethanol content. Because the observed rate of yeast in the prion state
was significantly different from what might be expected, given spontaneous [Psi+]
rates, this implied that the [Psi+]  prion state might actually be a disease, in other
words, somewhat toxic to yeast.  The same was observed with [Ure3]
(Nakayashiki et al. 2005).  This may contradict the theory that the [Psi+] state is
beneficial because it confers the ability to read through nonsense codons,
thereby allowing for an increase in genetic diversity under times of stress (Serio
and Lindquist 2001).
Specific examples, however, support the theory that prions can be
benefical.  For example, one study showed that the [Psi+] state confers an
increase in thermotolerance and chemical tolerance in some yeast strains
(Eaglestone et al., 1999).  In addition, the [Psi+] state was found to impart an
increase in genetic variation and phenotypic diversity (True and Lindquist, 2000;
True and Lindquist, 2004).  Furthermore, it is proposed that the lack of presence
of [Psi+] in the natural environment may be because the prion state need only
exist transiently to unlock genetic diversity conferred by the read-through of
various nonsense mutations and that the truly important traits will eventually work
their way into the genome, negating the need for the [Psi+] state (Shorter and
Lindquist, 2005; reviewed by von der Haar and Tuite, 2007). Another explanation
that has yet to be put forth in the publications on this issue revolves around
known beneficial effects of some known diseases. Just because a state is a
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disease state, in other words, somewhat toxic, does not mean that there is not an
accompanying beneficial impact found in that disease state.  The common
example of this is sickle cell disease conferring an increase in resistance to
malaria.
Evidence for a less controversial conferment of beneficial traits has been
found in Podospora with the [Het-S] prion state.  The [Het-S] state provides
Podospora fungi with the ability to fuse with normally incompatible fungi strains
(Coutou et al. 1997).  In addition, a group proposes that the behavior of the B
protease protein from S. cerevisiae should be considered to be a prion because
of the ability to convert itself into the active state when overexpressed, termed
the [β] state.  The state is self-propagating and involves its ability to act like a
protease on itself, removing a C-terminal expansion that inhibits activity, resulting
in the activation of the protein.  This state is stably inherited. (Roberts and
Wickner, 2003; Roberts and Wickner, 2004). In this example there is no
aggregation, so this is a large step away from more common prion concepts.
The authors, however state that the prion theory of PrP was held before it was
found to be an aggregate, therefore the definition of a prion as a protein-only
epigenetic switch is in accordance with the observed data in the [β]  state.  It is
proposed that the ability of protease B to self-activate in trans may be a much
more common type of prion, defined as mere epigenetic inheritance of a trait.  To
this end, it is proposed that other proteases, and possibly other protein-modifying
enzymes such as kinases, methylases, acetylases, or ubiquitin ligases may also
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be capable of being called prions if they modify themselves, resulting in a self-
propagating state (Wickner et al., 2004).
Going by this definition, it does seem as though many proteins can be
termed prions.  Also, what is considered maintenance of the prion state?  In
Podospora and yeast, replication is fast, so the propagation of an epigenetic
“prion” state is easily observed.  The question arises, however, as to how to
define a prion state in post-mitotic cells, like neurons.  In other words, how is
propagation classified when there are no cellular progeny.  This is actually
important because in the case of Sup35, the cells are considered “cured” even
though the parent yeast cell still retains aggregates.  It is only the breakdown of
the aggregates into smaller oligomers that can be passed to daughter cells that is
impaired (see more details later in this chapter).  In addition, it has been
proposed that a neuronal Aplysia protein, CPEB, can act like a prion and that the
putative prion-like state of this protein could be induced by synaptic activity.  The
conversion to the prion-like state is proposed to be a mechanism for creating
long-term synaptic changes that may be involved in the formation of memory.  In
this case, the prion state is not propagated to daughter cells.  Aggregated
proteins are maintained as aggregates.  In these types of cases, one could
define a prion state as a local change that is locally propagated within a cell type
and maintained for a long period of time until a new signal reverses the prion
state by some mechanism.  In order for this to occur within one cell for a lengthy
period of time, however, there must be a tight regulation of the numerous
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aggregation-prone proteins in the cell.  Whether the evolutionary advantage, in
such cases, that is conferred by the prion state is sufficient for the amount of
energy necessary to prevent numerous toxic protein aggregates from forming in
these cells is yet to be determined.  Ultimately, the fact that many proteins, and
perhaps even all proteins, are capable of forming amyloid fibers under specific
conditions because of a general capability of all peptide backbones to form
hydrogen bonds with adjacent peptide backbones, and the propensity of certain
proteins to form aggregates, implies that the conservation of these amyloid-prone
sequences may have been for an important functional reason.
The background presented in this introduction provides numerous
examples where the specific terminology used when discussing aggregating
proteins and putative prions must be better universalized in order to provide
specific requirements for defining an actual prion.  As one learns more about the
universality of protein aggregation, attempting to define a subset of this group
becomes more difficult.  Should the term prion be reserved for only a few very
specific proteins, or might a prion state be more common than previously held?
Different groups offer different requirements for prion determination.  It is
proposed by some groups that any transfer of information without the use of
nucleic acids may be considered evidence of prions.  A further elucidation of this
concept is the possibility that any chromosomally derived protein, which is
capable of altering its own conformation and is capable of carrying out the
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conformation change of its own endogenous, normal form is a prion (Wickner et
al., 2004).
RESULTS
Pumilio Is a Candidate Protein Identified in a Database Search to Find
Possible Functional Prions in Drosophila melanogaster and Caenorhabditis
elegans
To search for proteins that might act as prion switches, we reasoned two
major things:  1) that many switch proteins, including transcriptional and
translational regulators, would contain an annotated nucleic acid binding domain;
2) if such a protein contained a glutamine/asparagine (Q/N)-rich sequence, this
would be unlikely to be present in its ortholog in a distantly related species, since
these Q/N sequences evolve very rapidly. If the Q/N sequence were maintained
in the ortholog, it would imply that it had been selected.  The argument is based
on the observation that Sup35p proteins in distantly related yeast species all
contain highly conserved EF functional domains attached to Q/N sequences. The
Q/N regions are not conserved at the primary sequence level, but amino acid
composition is maintained.  These data imply that the presence of the Q/N region
confers a selective advantage.  This was hypothesized to be due to selection for
the ability of the protein to convert to a prion state.
The Drosophila melanogaster and Caenorhabditis elegans proteomes
were searched for predicted proteins that contain nucleic acid binding domains
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(for RNA, DNA, or both), and Q/N-rich sequences, using a threshold of 30 Q/Ns
in 80 residues.  This is the same threshold used in a search for new, putative
yeast candidates (Michelitsch and Weissman, 2000).  As described above, we
specified that the ortholog in these two very distantly related species must
contain both the Q/N rich domain and the nucleic acid binding domain in order to
show that Q/N rich region is important for function, and has, therefore, been
maintained.  To this extent, candidate genes obtained by the search of these two
species databases, would be blasted and orthologs analyzed for the
maintenance of a Q/N rich region and the functional nucleic acid binding domain.
Of the 472 Drosophila and 143 C. elegans Q/N- rich proteins previously shown to
exist, (Michelitsch and Weissman, 2000), only two orthologous pairs satisfied all
of the above parameters: Drosophila pumilio (Pum) and its worm ortholog Puf9,
and a pair of large chromodomain proteins.
Pum was already being studied in the lab, after being obtained in a
Drosophila larval neuromuscular junction (NMJ) overexpression/misexpression
screen (Kraut et al., 2001).  This screen involved taking the set of 2293 GAL4
driven EP element lines available at the time and crossing them to a pan-
neuronal GAL4 driver and a UAS-green fluorescent protein (GFP) line, then
looking at the third instar larvae NMJ for deviations from wild type. The neuronal
overexpression of Pum was found to produce an NMJ phenotype with numerous
tiny boutons.  Subsequently, Pum has been shown to be involved in translational
repression at larval (NMJ) synapses and to play a role in both growth and
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morphology of the neuromuscular junction (NMJ) synaptic boutons (Menon et al.,
2004).  Hypomorphic pum mutants were reported to have learning and memory
phenotypes in adult Drosophila (Dubnau et al. 2003).  A search through the
genomic databases reveal that Pum and its orthologs in other organisms,
including other arthropods such as members of the bee family and mosquitoes
also have Q/N rich regions. Human and mouse Pum2 proteins also have Q/N
rich sequences, although these do not surpass the threshold used in our search.
However, some Pum orthologs, including human and mouse Pum1, Pum2 from
bulls and dogs, or the more distantly related Arabidopsis, do not contain
sequences with significant Q/N enrichment.  If Q/N enrichment is really important
for normal protein function in fly and worm Pum proteins, perhaps other amino
acid sequences in these orthologs are playing the same role.  Interestingly, a
gene that had a lower Q/N count, but was also noted in the screen was Poly-A
Binding Protein, (PABP), which is another gene expressed at the synapse, is
involved in translation initiation, and is found in stress granules (see
Introduction).
Different Constructs of Pumilio Form Visible Aggregates in Yeast
Various plasmids were made from Drosophila Pum, C. elegans Puf9, and
various controls (Figure 1B) in order to visualize the overexpression of these
peptides in yeast.  In order to accomplish this, constructs were created that used
a copper-inducible promoter in conjunction with a cyan fluorescent protein (CFP)
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tag and a URA+ gene, which allows selection of transfomants in ura- strains.
The full-length Pumilio without the RNA-binding domain, the first Q/N repeat of
Pum (NQ1), the second Q/N repeat of Pum (NQ2), the first Q/N repeat of Pum
lacking the longest run of Qs (ΔNQ1), CFP alone, New1PrD (the N-terminal
aggregate-forming domain of a well-studied putative yeast prion), Sup35NM (the
aggregate-forming domain of another well-studied putative yeast prion that
confers the [Psi+] prion phenotype) fused to YFP, and the C. elegans Puf9
protein were analyzed for the ability to form aggregates when overexpressed
individually and with co-expression of Sup35 in specific yeast strains.
These constructs were transformed individually into [Psi+][pin+],
[Psi][pin+], and [Psi-][pin-] strains and visualized through confocal microscopy for
individual aggregates of the various Pum domains, as evidenced through the
presence of CFP foci, an established method for determining a protein’s ability to
aggregate in vivo in yeast.  All Pumilio constructs revealed obvious foci after 8
hours of overexpression (Figure 2 A-H).  CFP did not show any significant
aggregates at this time point (Figure 2A).  In addition, Sup 35NM seemed mostly
diffuse in the yeast cells (Figure 2B).  After 48 hours, however, all constructs,
including CFP, showed obvious aggregates (Figure 2I).  This data shows that
after a short period of induction only certain constructs are capable of forming
visible aggregates, however at later time points all overexpressed proteins may
be capable of aggregating under these experimental conditions.
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These constructs were also cotransformed with Sup35NM-YFP in order to
ascertain their ability to cause the aggregation of Sup35.  All constructs resulted
in Sup35-YFP aggregates.  Given the fact that Sup35 was capable of forming
aggregates when overexpressed on its own, however, this data is not surprising.
The various constructs, however, may be responsible for catalyzing the Sup35
aggregated state at an earlier time point.   Moreover, the aggregates seemed to
contain larger, brighter foci, implying an increase in aggregate formation, (data
not shown).
Pumilio Can Recapitulate the [pin+] Phenotype in Yeast
It is known that Sup35 requires the presence of another putative yeast
prion, [pin+], derived from RNQ1 in its aggregated form, in order to form the prion
[Psi+] state (Sondheimer et al., 2000).  Because another aggregated protein is a
prerequisite for Sup35’s ability to go from the [Psi-] state to the [Psi+] state,
overexpression of the various constructs were tested for their ability to reduce
Sup35 function, implying a [Psi+]  state. This is assayed by suppression of a
nonsense mutation of ADE1, an enzyme necessary for adenine production in the
yeast.  The presence of the nonsense allele normally results in the absence of
functional ADE1, so that the yeast fail to grow in the absence of adenine. When
Sup35 is not functional and, therefore, not capable of performing its role as a
termination factor, causing polypeptide chains to be released from the ribosome
when a stop codon is reached, the early stop codon mutation is read through and
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a functional protein is produced. This phenotype can be analyzed by counting
colonies that appear on –ADE plates when transformed strains are plated 48
hours after the initiation of overexpression of the cotransformed constructs.
In these experiments, the various constructs delineated in Figure 1 were
cotransformed with Sup35NM-YFP into a [Psi-][pin-] strain and grown for 48
hours after inducing overexpression with Cu+.  These were then plated on –Ade
plates and –Ura –Leu plates, and colonies were counted in order to determine
the percentage of  [Psi+], prion state induction.  This percentage was compared
with the levels of the positive control, New1Prd-CFP.  A yes on the table means
that the percentage of [Psi+] induction was comparable to those observed for
New1Prd-CFP (Figure 1B).  Co-overexpression of NQ1-CFP and Sup35NM-YFP
is observed to cause a decrease in nonsense suppression of ADE1, presumably
through the aggregation of Sup35 into a nonactive conformation, characterized
as the [Psi+] state, at the same or better rate as NEW1, a previously
characterized yeast prion (Osherovich and Weissman, 2001) (Figure 1B and data
not shown).  New1 has already been shown to act in a manner comparable to the
[pin+], prion state, which is required for the efficient induction of the Sup35 prion
state (Derkatch et al., 2001) . FLPum, Puf9, and NQ2 seem to be able to induce
the Sup35 state, but may do so at lower efficiency.  ΔNQ1 cannot induce the
[Psi+] state at the same efficiency as the other constructs.  Neither Sup35 nor
CFP seem to be capable of inducing the [Psi+] state to a significant extent
(Figure 1B and data not shown).
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A Pumilio-Chimera Diploid Can Result in a [Psi+] State in Yeast When the
NQ1 Region of Pumilio Is Overexpressed
In order to test if the NQ1 region of Pum was capable of replacing the
aggregating domain of Sup35, a chimera was made consisting of the Pum NQ
domain and the RNA Binding domain (EF) of Sup35, and integrated into a diploid
genome, replacing one copy of the endogenous Sup35 (Figure 3).  Resulting
transformed lines, as determined by presence of a His tag, were then sporulated
and dissected in order to obtain haploid yeast lines.  PumNQ1-Sup35-EF,
however, did not seem viable in the haploid state because only two yeast
colonies were consistently obtained after tetrad dissections, perhaps indicating
that yeast expressing only the chimera fail to survive.  Of the very few putative
haploid colonies that actually resulted from surviving tetrads, only two lines seem
to contain NQ1 by PCR analysis.  This result has been observed in the
production of similar chimeras that seem to aggregate very strongly, thereby
reducing the availability of the necessary element Sup35 to such a degree that
the line is lethal (Cameron and Weissman, unpublished data).  Complete Sup35
knockouts are known to be lethal.
Both of the isolated lines still contained the N-terminus of Sup35, which
should have been excised by the integration method (Figure 3).  This implied that
the NQ1-SupEF hybrid gene either integrated elsewhere into the genome, and
the endogenous Sup35 was retained, or the lines were diploid.  Both lines seem
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capable of sporulating and forming tetrads, implying both were diploids, but
mating tests seemed to show the ability of one of these lines to mate to one
mating type of yeast, implying that this line might possess haploid qualities and
actually be a triploid.
In order to generate a [Psi-][pin-] version of this putative chimera line for
use as a recipient for Pum constructs, this line and the parent [Psi+] diploid strain
were treated with Gu-HCl (see below for details) and derivative lines that formed
red colonies on a YPD plate were chosen for use in subsequent experiments.
When the lines bearing NQ1-Sup35EF hybrid genes were transformed with the
same constructs as used in the previous set of experiments (Figure 1B) at the
same time as the similarly transformed diploid [Psi-] strain as a control, the NQ1-
Sup35EF lines were capable of significantly increasing (more than 10 fold) the
induction of  [Psi+] above the control diploid line when both Sup35NM-YFP and
NQ1-Cfp, or Sup35NM-YFP and New1-CFP were overexpressed in these lines
(Figure 4).  Furthermore, the double overexpression of Sup35NM with ΔNQ1-
CFP did not result in a similar increase of induction.  Although this line is not well
characterized, this data provides more supporting evidence that NQ1 can act in a
manner similar to New1 as far as inducing the [Psi+] state.  Even if the data from
the putative chimera is disregarded, the data from the cotransformation of either
NQ1 or New with Sup35NM into the diploid strain reveals similar rates of [Psi+]
induction as each other and as the results that were observed in haploid lines,
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again supporting the concept that NQ1 is capable of inducing the Sup35 prion
state to the same extent as the N-terminal of New1 (Figure4).
The [Psi+] state induced by Pumilio is reversible in the presence of
Guanidine HCL
The [Psi+] state, characterized by growth of yeast on –ADE plates and
white yeast on rich medium plates is reversible in the presence of Guanidine-HCl
(Gu-HCl).  Low levels of Gu-HCl, a known chaotropic agent that can unfold
proteins, is a common method used in yeast for showing that the prion state is
interconvertible with the native state and that the prion state is reversible (review,
Jones and Tuite, 2005).
  Gu-HCl is capable of reversing the prion state of the putative chimera
and the [Psi+] state induced by Sup35NM and NQ1 overexpression.  This data
from the putative chimera line implies that perhaps NQ1 is capable of being
cured, at least to the extent of not maintaining the Sup35 prion state.   The data
presented here shows that NQ1 is capable of acting in a manner similar to the N-
terminal of New1, which has been shown to be a “stronger” prion in several
assays than RNQ1 (Derkatch et al., 2004), and is capable of acting like [pin+]
(Osherovich et al. 2001). In addition, one may hypothesize that if the putative
chimera NQ1-EF line was not cured by Gu-HCl, then the [Psi+] prion state could
possibly be maintained.  It is possible, however, that the lack of HSP 104 is
sufficient to cure only the Sup35 prion and does not impact NQ1-EF.
42
Discussion
The first NQ-rich domain of Pum (NQ1), the second NQ-rich domain
(NQ2) of Pum, the full-length region of Pum, lacking the RNA-binding domain, as
well as the pumilio ortholog, Puf9, in C. elegans can act in a manner similar to
putative yeast prions in vivo.  The domains aggregate when overexpressed in
different strains of yeast, can act in a manner similar to [New+] in nonsense
suppression assays with Sup35, and the putative NQ1-EF prion state may be
reversible when grown on Guandine-HCl (Gu-HCl).  In the assays analyzed,
these domains of Drosophila Pum and the C. elegans ortholog of Pum seem to
act in a prion-like manner to the same extent as the previously characterized
putative yeast prion New1.
In the yeast aggregation assay, specific Pumilio domains aggregate in
vivo as observed through confocal microscopy and result in CFP foci that are
visually similar to those observed in well-studied putative yeast prions.  Longer
incubation times result in more localized, larger foci, which is also consistent with
previous observations of yeast prions, polyQ proteins, and other known amyloid
forming proteins overexpressed in similar strains of yeast.  Introducing another
prion state, [pin+], [Psi+], or both, results in larger aggregates.  This is also
consistent with previous observations.  As a negative control, data was also
conducted on a vector containing only CFP.  At early time points a lack of CFP
foci are observed when overexpressed in [Psi-] [pin-] lines, with CFP expression
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diffuse throughout the yeast cell.  Longer incubations, however, result in yeast
overexpressing only CFP starting to show aggregates.  This data is consistent
with the observation that overexpressed proteins in general are capable of
forming aggregates, such as numerous overexpressed proteins in E. coli and
other organisms.  This is also consistent with the hypothesis that endogenous
proteins are expressed at a level comparable to their ability to form aggregates
(Tartaglia et al., 2007), implying that the overexpression of many proteins could
lead to in vivo aggregation.
It is well known that overexpression of many proteins in E. coli result in
aggregation and the formation of inclusion bodies, which may support this
concept.  E. coli, however are prokaryotes with different cellular attributes, so the
comparison between the two organisms is not necessarily true.  Even though it
may be possible for all proteins to form aggregates in yeast when overexpressed,
there is still an obvious rate difference, with some proteins capable of forming
visible aggregates at a much earlier time point when overexpressed.  In addition,
the yeast prion state can form spontaneously, albeit at a very low frequency for
most putative yeast prions.  Even so, this is not necessarily catalyzed by
overexpression of the protein, although it might be.  Ultimately these yeast
assays may be sufficient to distinguish between proteins that might be more
capable of readily aggregating in vivo, versus proteins that may take longer to
aggregate or might require a higher expression level in order to start aggregating.
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The effects of Gu-HCl on reversing the prion state in yeast are known to
act through HSP104, the chaperone required for the formation of oligomers and
for the creation and maintenance of prion state (Ferriera et al., 2001).  In a
HSP104 deletion strain, the prion state of any putative yeast prion cannot be
induced or maintained (Chernoff et al., 1995). Furthermore, it has been shown
that Hsp104 is actually the protein that is affected by Gu-HCl, and that it is the
inactivation of HSP104 by Gu-HCl that leads to the reversibility of the prion state
(Ness et al., 2002).  It has also recently been shown that cell division is required
for the elimination of the [Psi+] prion state with Gu-HCl (Byrne et al., 2007).
These details about the function of Gu-HCl in “curing” yeast actually call into
question the ability of this assay to be a real measure of prion reversibility in the
sense that it is not the Sup35 aggregated state that is reversed, but the ability to
pass the aggregated state on to daughter cells.    This data implies that Gu-Hcl
does not actually cause a switch in the protein conformation of aggregated
proteins in the prion conformation, but rather affects the ability to seed the
aggregation in progeny.  If one considers the fact that PrP has not yet been
shown to be reversible, however, perhaps the requirement for the reversibility of
the prion state needs to be redefined or eliminated.  This is especially the case if
one considers a putative prion that resides in postmitotic cells, because the
ability to pass on the prion state to progeny cells is irrelevant.  In addition,
diseases that form seemingly nonreversible aggregate clumps may be more
similar to proteins that are capable of being cured by Gu-HCl than previously
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believed.  This also implies that assays that induce the overexpression of HSP
104 may actually be a better diagnosis of the reversibility of the prion.  The
overexpression of HSP 104, however, seemed to only cause the loss of the prion
state in a very small set of prions tested (Weissman lab, unpublished data), yet
still termed yeast prions.
It also seems as though NQ1 is capable of inducing Sup35 into the prion
state at a rate comparable to New1.  This is very interesting in that this specific
assay was originally used by Weissman to prescreen through the numerous N/Q
rich yeast proteins for yeast that could act like prions in the other typical prion
assessment assays.  This assay seemed to only work with proteins that were
later considered yeast prions (Osherovich, 2001).  In addition, NQ1 consistently
showed similar [Psi+] induction rates as New1Prd, showing that it may possess
similar properties to New1.  It has been proposed that the N/Q rich sequences
are capable of directly seeding Sup35 aggregate formation (Derkatch, 2004).
The Q rich domain of NQ1, therefore, may be responsible for its ability to induce
the [Psi+] state, which is substantiated by the fact that the removal of the longest
run of Qs results in a decrease in Sup35 induction into the prion state.
The fact that many proteins, and perhaps even all proteins, are capable of
forming amyloid fibers under specific conditions because of a general capability
of all peptide backbones to form hydrogen bonds with adjacent peptide
backbones, implies that the conservation of these Q/N rich, amyloid-prone
sequences may have been for an important functional reason.   Given the latest
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knowledge about general protein folding, misfolding, and aggregation, it seems
as though the initial search paradigm used to find putative beneficial prions may
have overlooked numerous proteins that still maintain a strong propensity
towards aggregation, yet lack large Q/N repeats, such as PrP itself.
Furthermore, the precise cutoff number of 30 residues in 80 may be an
overestimation of the number of Q/Ns really required to form a transmissible
aggregate.  In addition, confining the search to domains that are involved in
nucleotide binding also possibly reduced the number of hits. It now seems that
numerous functional types of proteins can be considered prions as long as they
show an epigenetic propagation (see Chapter 1 introduction).  This could include
proteases, ubiquitin ligases, acetylases, methylases, etc. (Wickner et al., 2004).
Even so, the database search for proteins that might be involved in an epigenetic
switch still produced a very interesting candidate, Pum, and another interesting
protein, PABP, which may actually interact with Pum at NMJ synapses.
Experimental Procedures
Yeast Strains and  Plasmids
Yeast plasmids were obtained from Jonathan Weissman (Osherovich and
Weissman, 2001). The n-terminal prion domain of New1, amino acids 1-153, was
tagged with eCFP and under control of the CUP1 promoter within the pRS426
(URA3) plasmid.  Sal I and Bgl II sites in this vector were used to remove the
New1 sequence and the specific regions of Pum and Puf9 were obtained through
PCR of cDNA clones, subcloned into topo vectors, then digested and ligated into
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the PRS426 vector.  A plasmid containing exon 1 of Huntingtin with 46 Qs was
obtained from Pamela Bjorkman and PCR was conducted to insert appropriate
restriction sites.  This was also subcloned into a topo vector, then digested and
ligated into the pRS426.  Sup35NM was obtained in the pRS425 (LEU2) plasmid
tagged with YFP.     [Psi-] [pin-], [Psi-][pin+], and [Psi+][pin+] yeast strains
derived from 74D-694 MATa adel-l4(UGA) trpl-289(UAG) hzs3A-200  ura3-52
leu2-3,112, and W303 strains containing ade1-14 (Osherovich and Weissman,
2001) were used in these studies. In addition, a [Psi+][pin+] diploid with the same
background was also obtained for genomic integration experiments.
In Vivo Aggregate Visualization Under Confocal Microscopy
The Zeiss LSM 510 inverted microscope was used for obtaining images
and visualizing foci.  Appropriate lasers were used, possessing wavelengths to
excite CFP and YFP.  Random fields were scanned and images represent the
majority of yeast observed. Z slices were taken using .25 µm intervals.
Chimera Creation and Chromosomal Integration
A chromosomally integrated gene fusion of the NQ1-Sup35EF chimera
was generated by homologous recombination of PCR-amplified sequences
containing a His tag.  These were transformed into diploid yeast strains, and
grown up on –His plates.  Resulting colonies were PCR screened for the
presence of NQ1 and the N-terminus of Sup35, which should have been excised,
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and appropriate strains were sporulated using standard procedures, dissected,
and grown up on YPD plates.
Guanidine-HCl treatment
  Yeast were grown on minimal media plates containing 5mM Guanidine-
HCl for 5-7 days at 30°C.   Colonies were then streaked out on –ADE plates in
order to show loss of [Psi+] state and on YPD plates in order to better visualize
color reversion.
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Figure Legends
Figure 1 (A)  Drosophila Pumilio Domains.  After analyzed the sequence of Pum,
two large Q/N rich tracts were observed: the first Q/N-rich tract (NQ1) and the
second (NQ2) region, as well as the RNA binding and Puf domain regions. (B)
Because Pum is a very large protein and endogenous yeast prions are
significantly smaller, we decided to construct several yeast-expressing plasmids,
in case the bulky nature of FL-pum was difficult to efficiently express.  The
Sup35NM region and the New1 constructs were used as positive controls for
some assays and the same yeast plasmid containing only CFP was used as a
negative control.  The ability for each of the constructs to form aggregates in [Psi-
][pin-] yeast strain is shown at 6 hour and 48 hour timepoints.  The ability of the
construct to induce the [Psi+] state when overexpressed in [Psi-][pin-] yeast
strains along with Sup35NM-YFP is also shown.  Yeast were induced at OD 6
and grown at 30°C in both experiments.  The yeast were plated after 48 hours of
growth onto –ADE plates to analyze the prion state.
Figure 2.  Visualization of CFP aggregates in [Psi-][pin-] Yeast.  Yeast were
analyzed on an inverted 510 Zeiss confocal microscope for the ability to form
aggregates (A-H) [Psi-][pin-] yeast strain transformed with the one of the
constructs described in Figure 1., and analyzed after 6 hours of induction by
copper, and  (I-L) analyzed after 48 hours of growth at 30 degrees in the
presence of copper.
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Figure 3.  Drosophila melanogaster Pumilio amino acid sequence with Q/Ns
highlighted
Figure 4.  A schematic diagram describing gamma integration, the method used
to attempt to replace one copy of genomic Sup35 with an NQ1-Sup35-EF
chimera.
Figure 5.  Percent of [Psi+] induction in yeast in an NQ1-EF chimera strain.  The
X-axis contains the yeast strain used for these experiments, and the plasmid or
plasmids transformed into the strain and induced by copper for 48 days prior to
plating on –ADE plates, and diluted and plated on either –Ura, -Ura –Leu, or
–Leu, depending on the plasmid(s) used.  The percent of [Psi+] induction was
determined by dividing the number of yeast that grew on –ADE plates by the total
number of transformed yeast and multiplying by 100.  The Gd-HCl cured NQ1
diploid strain is the putative NQ1-EF chimera line diploid.  The control diploid
strain is the original parent strain used in the gamma integration procedure, but
cured with GdHCl to eliminate the [Psi+] state.
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Figure 1.  (A)  Drosophila Pumilio Domains
  (B)  Yeast Plasmid Constructs and Ability to Aggregate or Induce the
   [Psi+] state
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Figure 2.  Visualization of CFP aggregates in [Psi-][pin-] Yeast
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MKFLGGNDDRNGRGGVGVGTDAIVGSRGGVSQDAADAAGAAAAAAVGYVF
QQRPSPGGVGVGVGGVGGGVPGVGAVGSTLHEAAAAEYAAHFAQKQQQTR
WACGDDGHGIDNPDKWKYNPPMNPANAAPGGPPGNGSNGGPGAIGTIGMGSGL
GGGGGGGAGGGNNGGSGTNGGLHHQSMAAAAANMAAMQQAAALAKHNHMI
SQAAAAVAAQQQHQHPHQQHPQQQQQQQQAQNQGHPHHLMGGGNGLGNG
NGLGIQHPGQQQQQQQQQQQQQHPGQYNANLLNHAAALGHMSSYAQSGGS
MYDHHGGAMHPGMNGGMPKQQPLGPPGAGGPQDYVYMGGQTTVPMGAAM
MPPQNQYMNSAAVAAANRNAAITTSTAKKLWEKSDGKGVSSSTPGGPLHPLQI
PGIGDPSSVWKDHTWSTQGENILVPPPSRAYAHGGASDTSNSGNAGILSPRDSTC
AKVVEYVFSGSPTNKDSSLSGLEPHLRNLKFDDNDKSRDDKEKANSPFDTNGLK
KDDQVTNSNGVVNGIDDDKGFNRTPGSRQPSPAEESQPRPPNLLFPPLPFNHML
MDHGQGMGGGLGGVVGSGNGVGGGSGGGGAGGAYAAHQQMAAQMSQLQP
PMMNGVGGGMPMAAQSPMLNHQAAGPNHMESPGNLLQQQNFDVQQLFRSQ
NPGLAAVATNAAAAAAAAAAATSAASAAAAVGAPPVPNGSLQQSQQQQQQQ
QQQQQQQQMHMAAASQQFLAAQQQAQNAAYAAQQATSYVINPGQEAAPY
MGMIAAAQMPYYGVAPWGMYPGNLIPQQGTQPRRPLTPSQQGAENQPYQVIP
AFLDHTGSLLMGGPRTGTPMRLVSPAPVLVPPGATRAGPPPPQGPQLYQPQPQT
AQQNLYSQQNGSSVGGLALNTSSLTGRRDSFDRSTSAFSPSTMDYTSSGVAAAA
NAVNSTVAQAAAAAAAAAAARGKWPGAMSGAASGAYGALGAGNASASPLGA
PITPPPSAQSCLLGSRAPGAESRQRQQQQQQLAAVGLPATAAAAQAAVAAAAN
NMFGSNSSIFSNPLAIPGTAAVAAAAAAAAAANSRQVAATAAAAAAVAAAAGG
VGGAPQPGRSRLLEDFRNQRYPNLQLRDLANHIVEFSQDQHGSRFIQQKLERAT
AAEKQMVFSEILAAAYSLMTDVFGNYVIQKFFEFGTPEQKNTLGMQVKGHVLQ
LALQMYGCRVIQKALESISPEQQQEIVHELDGHVLKCVKDQNGNHVVQKCIEC
VDPVALQFIINAFKGQVYSLSTHPYGCRVIQRILEHCTAEQTTPILDELHEHTEQLI
QDQYGNYVIQHVLEHGKQEDKSILINSVRGKVLVLSQHKFASNVVEKCVTHAT
RGERTGLIDEVCTFNDNALHVMMKDQYANYVVQKMIDVSEPTQLKKLMTKIRK
NMAALRKYTYGKHINAKLEKYYMKITNPITVGTGAGGVPAASSAAAVSSGATS
ASVTACTSGSSTTTTSTTNSLASPTICSVQENGSAMVVEPSSPDASESSSSVVSGA
VNSSLGPIGPPTNGNVVL
Figure 3   Drosophila melanogaster Pumilio Amino Acid Sequence With Q/Ns
Highlighted
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Figure 4.  Gamma Integration, the Method for Replacing Endogenous Sup35
with NQ1-EF in the Yeast Genome
PCR
55
Figure 5.  Percent of [Psi+] Induced Yeast in an NQ1-EF Chimera Strain
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Chapter 2 Introduction
Drosophila melanogaster is one of the best species for investigating many
basic science questions and also for investigating human diseases.  It is a small
invertebrate that is easy to maintain and propagate, contains an enormous array
of molecular and genetic tools, is well-characterized, and at least 50% of
Drosophila genes are similar to those found in humans (Rubin et al., 2000), with
at least 75% of genes associated with human diseases containing a Drosophila
ortholog (Reiter et al., 2001).  Specifically, the Drosophila neuromuscular junction
(NMJ) is an ideal model system for studying neuronal connections.  One can
make use of the attributes of the fruit fly delineated above, while having the ability
to observe single cell synapses and conduct electrophysiological measurements
(Keshishian et al., 1996).  The Drosophila NMJ contains glutamatergic synapses
that are homologous to mammalian AMPA receptors and can be used as a
model for glutamatergic synapses in the mammalian CNS because of the
molecular and developmental similarities between the two.  At the Drosophila
NMJ, synapses occur at axonal swellings, termed boutons.
Synapses are the primary location where the transfer of information
between neurons, or from neurons to muscles, takes place.  Synapses contain a
presynaptic density, which is associated with synaptic vesicles and termed the
active zone, and a postsynaptic density (PSD) directly across a cleft from the
active zone.  Synapses are quite remarkable in their dynamic nature, with an
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ability to maintain stable connections for long periods of time, or the ability to
rapidly disassemble or form (Eaton and Davis, 2003).  Although the assembly
and disassembly of synapses is especially common during development, it has
been shown that synapses retain the ability to change throughout the existence
of an organism (Purves and Lichtman, 1980).
Many recent studies have led to a detailed description of the proteins
involved at the synapse and their regulation.  It is now commonly believed that
mRNAs are targeted to the synapse and are translated in response to neuronal
activity, which was first postulated when polyribosmes were discovered at the
base of dendritic spines (Steward and Levy, 1982).  Various mRNAs have been
discovered at the synapse.  These include mRNAs encoding microtubule-
associated protein 2 (MAP2), the α-subunit of Ca2+/calmodulin-dependent
protein kinase II (CamKIIα), and different neurotransmitter receptor subunits
(reviewed by Martin and Zukin, 2006).  It has also been discovered that local
protein synthesis in dendrites seems to be involved in moment-to-moment
regulation of synapses, hypothesized from the observation that the spontaneous
release of neurotransmitter has a repressing effect on local protein translation
(Sutton et al., 2004; Sutton et al., 2006).   Although polyribosome-containing
mRNAs are constantly localized at synapses, the mRNAs do not seem to be
translated until they receive a signal, one of which can be initiated through
neurotransmitter binding to receptor.   In addition, postsynaptically induced
neurotransmitter cascades seem to be involved in local protein synthesis and
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may cause long-term changes in synaptic function (reviewed by Schuman et al.,
2006).  Given the observation that local protein translation can be repressed in
response to activity, the proteins involved in mRNA translational repression are
important to study in order to further elucidate how synaptic connections are
formed and maintained.
An mRNA binding protein that is involved in translational repression
(Wharton et. al., 1998) and is found at synapses of the Drosophila NMJ, is
pumilio (Pum) (Menon et al, 2004). Pum is a 1533 amino acid protein containing
13 exons that spans greater than 200kb of DNA (Macdonald, 1992).  Several
Pum isoforms have been observed.  There are a 156 kD protein (Barker et al.,
1992).  There are also a 130 kD isoform (Parisi and Lin, 1999) and a 95 kD
isoform (Schweers et al., 2002).  Full length Pum contains a Q/N rich N-terminal
domain and an RNA binding C-terminal domain containing several puf motifs.
The C-terminus has been shown to be involved in binding to Nanos (Nos) and
Brain Tumor (Brat), as well as to RNA targets (Edwards, 2001).
Pum is a well-characterized protein that was first described in its role as a
regulator of Drosophila embryonic development.  Maternally synthesized pumilio,
along with Nos, another translational repressor, has been shown to bind to nanos
response elements (NREs) at the 3’ untranslated region (utr) of hunchback
mRNA in order to attain correct abdominal pattern formation (Barker et al., 1992).
The repression of hunchback mRNA at the posterior of the embryo occurs when
Pum recruits Nos and another protein, Brat, to the hunchback mRNA, allowing
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for hunchback expression only at the anterior end of the embryo (Sonada and
Wharton, 1999, 2001).  This is because Nos is localized in a gradient at the
posterior end, which provides a spatial repression mechanism, even though the
hunchback mRNA is distributed throughout the embryo (Gavis and Lehmann,
1994).
Although there is much information about the role of Pum in the embryo,
only a few more recent papers have contributed more information about the role
of Pum at later stages.  Pum was shown to localize to granules in the spines of
dopaminergic neurons and may be comparable to stress granules seen in
mammalian dendrites, (see thesis Introduction).  These granules, however, may
be a protein repression complex containing Nos, Pum, and other proteins
necessary for repression at the synapse (Ye et al., 2004).  In addition, Pum
hypomorphs possess associative memory phenotypes (Dubnau et al., 2003).
Pum has been shown to be involved in regulating the morphology and growth of
synapses at the fly NMJ (Menon et al., 2004). Pum is primarily localized to the
postsynaptic side of the larval NMJ and seems to be a regulator of local mRNA
translation.  In pum mutants, synaptic morphology is altered, an increase in local
translation of the eIF-4E translation initiation factor is observed, and an increase
of the GluRIIa glutamate receptor subunit at the neuromuscular junction is also
evident.  This data provides an interesting new role for Pum, and perhaps some
of the other proteins that are also involved in germline development.
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 Given the experimental data that shows that Pum is involved in synaptic
growth and changes in dendrite and NMJ synapse morphology, in addition to the
possible role of Pum in associative learning, it is intriguing to hypothesize about
overexpressed Pum’s ability to aggregate in vivo in yeast.  Learning and memory
require synapses to be able to maintain their characteristics for longer periods
than the lifetimes of any proteins within the synapse.  Since prion aggregates can
be inherited, a prion within a synapse should be maintained indefinitely after it is
induced. In addition, any new prion proteins synthesized at the synapse would
become incorporated into the old aggregates.  If such a protein regulated
synaptic local translation, it would then be possible for a translational state to be
maintained for long periods of time by an activity-regulated conversion of the
protein to a prion form.  This could represent a form of synaptic long-term
memory.  In this model, the prion state does not have to be infectious in the
sense of passing on the trait to a daughter cell, given the lack of division of these
neurons.  The putative prion, however, must possess a metastable state that
enables the aggregated form to avoid normal protein degradation and continue to
recruit newly created proteins.  Chaperones may be required to maintain or
degrade such an aggregated state.  In a recent paper, Eric Kandel and his
colleagues described some evidence that such a prion might exist at Aplysia
synapses, whose strength can be regulated by local translation (Si et al. 2003).
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Results
PUASP Derived NQ1 Transgenic Fly Lines Show Normal Embryonic
Segmentation
In order to analyze the ability of the first NQ-rich region (NQ1) of Pum’s
ability to cause the aggregation of endogenous, full-length Pum, I created a
construct that contained the NQ1 region of Pum tagged with GFP under control
of the UAS Gal4 system.  I used a pUASP contruct that contains changes in the
3’utr of the pUAST expression vector, a common Drosophila vector used for
chromosomal insertion containing 5 copies of the GAL4 binding sites, UAS,
surrounded by transposable P elements, for insertion into the fly genome, that
enable maternal expression during oogenesis, something that the pUAST
construct can not do very well. The use of pUASp has allowed assessment of
gain-of-function maternal phenotypes (Rorth P, 1998).  This vector was inserted
into flies and transgenic fly lines were obtained.
About 200 independent lines containing the NQ1 region of Pumilio tagged
with CFP under the control of UASp were generated.  About 100 of these lines
were mapped to the appropriate chromosome and balanced, with 11 X-
chromosome lines, 41 2nd-chromosome lines, and 61 3rd-chromosome lines.  I
obtained 10 different Gal4 drivers inserted on different chromosomes in order to
further analyze early embryonic expression of these lines. All balanced lines
were analyzed for CFP expression by crossing to several ovary drivers and
looking at early stage embryos.   No obvious aggregates of CFP were observed.
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All lines were categorized according to CFP expression levels on a scale from 1-
10 with 10 being the brightest.  All lines were also examined for decreases in
abdominal segmentation as observed in loss of function Pum (Barker, 1992)
through a cuticle preparation on stage 12 embryos by crossing to various ovary
drivers.  All 100 lines were analyzed with at least one driver.  The lines that
seemed to reveal the strongest CFP expression were analyzed with all of the
drivers.  There were no observed alterations in number of abdominal segments
or gross morphology of the embryos.
Creation and Characterization of PUAST-NQ1 PUAST-ΔNQ1 Transgenic
Lines 
Because the pUASP construct has been reported to show lower levels of
expression in larvae and adults than the pUAST vector, I created two new
constructs, one containing NQ1 in a pUAST vector and another construct with a
deletion of NQ1’s longest Q run, as described in the previous chapter (ΔNQ1)
and (deltaNQ1). About 500 independent lines containing the NQ1 region of
Pumilio or the ΔNQ1 region of Pumilio tagged with CFP under the control of UAS
were generated.  About 200 of these lines (100 of NQ1 and 100 of delta NQ1)
were mapped to the appropriate chromosomes and have been balanced.  Some
lines seem to have multi-colored eyes, suggesting multiple insertions of the
plasmid.  All balanced lines were analyzed for CFP expression by crossing to
elav, which drives expression in all postmitotic neurons, and to elav-GAL4;24B-
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GAL4, a double driver that includes both a post mitotic neuronal driver and a
muscle driver, and looking at early stage embryos under a fluorescent
microscope.  They were categorized on a scale from 1-10, with 10 being the
brightest.  Adults from these 200 balanced lines were analyzed in order to
observe eye color phenotypes.  All lines were also crossed to GMR-GAL4, a
driver that expresses in all cells of the eye, including neurons and supporting
cells (Ellis et al., 1993), or Tub-GAL4 (Lee and Luo, 1999), a ubiquitous GAL4
driver, to look for possible rough eye phenotypes.  Only very slight rough eye
phenotypes were observed.  A subset of lines (some with the brightest cfp,
darkest eye color, or rough eyes) were analyzed further by crossing to c155-
GAl4;24B-GAL4, c155-GAL4;elav-GAL4, a strong postmitotic neuronal double
driver, and 24BGAL4, and dissecting third instar larvae.  NMJ larval phenotypes
of promising lines were analyzed.
A Domain of Pumilio Shows an Increase in 1s and 1b Boutons When
Overexpressed in Muscles in a Pum Heterozygote Mutant Background
Various different mutant alleles of Pum were used to determine if
decreasing the expression of full-length Pum might have an impact on results
observed in these experiments.   Msc, et7, and et9 are 3 different mutant alleles
of pum that were used.  et7 and et9 are both mutations caused by ethane
methane sulfonate (EMS) induction that results in premature stops in the RBD
region of Pum.  Msc, on the other hand, is an inversion containing a breakpoint in
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the eighth intron of pum.  Strong phenotypes of each of these lines have been
observed in the early embryo, including a decrease in abdominal segmentation
(Forbes and Lehmann, 1998).  Msc revealed a weaker phenotype at the larval
NMJ (Menon et al., 2004).  Furthermore, both et7 and et9 mutant alleles still
produced protein that stained with anti-PumN, a rabbit antibody made against the
N-terminal region of Pum from amino acids 408-883 (Forbes and Lehmann,
1998) and anti-PumRBD, a mouse antibody made against the RBD region of
Pum from amino acids 1093-1533 (Sonoda and Wharton, 1999).  Although there
was a visible decrease in antibody staining in et7/et9 lines when stained with
anti-PumN, this decrease was less strong when anti-PumRBD was used (Menon
et al, 2004).  In addition, in Western blot analysis, the two larger wild-type Pumilio
isoforms are decreased in lysates produced from et7/et9 larvae body walls;
however, the third and smallest, 93kD isoform, is increased (Menon et al., 2004).
This data implies that the et7 and et9 lines are still producing a protein
Two types of boutons were analyzed in this study.  Type 1b boutons are
larger boutons that stain much more strongly with a specific post-synaptic
antibody α-Discs-large (dlg).  Type 1s boutons are smaller and have a weaker
dlg staining pattern (Figure 1a and 1b).  It has been shown that a significant
increase in type 1s boutons occurs in et7/et9 lines and that this increase can be
rescued only by expression of Pum in muscle, with a weak muscle driver to avoid
lethality.  In contrast, a decrease in 1b boutons was observed in et7/et9 lines,
and this phenotype could only be rescued by driving neuronal expression of Pum
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with elav.  This data implies that the neurons and muscles have different impacts
on the bouton numbers.  Different UAS-NQ1 lines were crossed to 24B-GAL4
and grown at 29 degrees. Live third instar larvae were dissected, fixed, and
stained with anti-Discs-large (dlg), a mostly post-synaptic marker that recognizes
a protein located under each bouton at the subsynaptic reticulum, and a
Tetramethyl Rhodamine Isothiocyanate (TRITC), a derivative of rhodamine)
conjugated anti-HRP antibody, that recognizes a neural specific carbohydrate
antigen in Drosophila and other insects.  Boutons on muscle 4 were counted.
Control lines which contained w118 x 24B-GAL4 and w118 x UAS-NQ1 were
also analyzed, as well as UAS-ΔNQ1 x 24B-GAL4.  There was no significant
difference in 1s or 1b bouton number among any of the lines (Figures 2a and 2b).
 UAS-NQ1 lines, w118, and UAS-ΔNQ1 lines were crossed to et9,24B-
Gal4/tm6b recombinant lines (Menon et al., 2004), stained as above, and
boutons were counted.  A highly significant increase in both type 1s and type 1b
boutons was observed (Figures 1, 2A, and 2B, and data not shown).   An
increase in both type 1a and type 1b were also observed when UAS-NQ1 lines
were crossed to msc,24B-Gal4/tm6b (data not shown). UAS-ΔNQ1 lines showed
no significant change in bouton counts for either type 1s or type 1b boutons and
were comparable to controls (Figures 1, 2A, and 2B and data not shown).
 Lethality Caused by Full-Length Pumilio Overexpression in Muscle Is
Rescued by Overexpression of the NQ1 Region of Pumilio
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A UAS-NQ1 line was recombined with UAS-full-length Pum (FLPum)
containing either the 3’ untranslated region (utr) of pum or the 3’utr of tubulin (a
strong ubiquitous promoter).  Approximately 50 different lines were obtained.
Several of these recombinant lines, and a line created from multiple crosses
containing UAS-NQ1 and UAS-FLPum on different chromosomes, were crossed
to 24B-GAL4 to check for any changes in phenotype.  UAS-FLPum containing
the 3’utr of pum or the the 3’utr of tubulin are lethal when crossed to 24B and
grown at 29°C, but escapers are present with UAS-FLPum containing the pum
3’utr at lower temperatures (Menon et al., 2004).  UAS-NQ1 was able to rescue
the observed lethal phenotype at 29°C, with larvae surviving until eclosion.  An
interesting eclosion phenotype was observed only with the UAS-NQ1, UAS-
FLPum lines crossed to 24B.  No adult flies could fully eclose from the pupae, yet
most flies appeared to survive until the point of eclosion, and some even partially
eclosed (Figure 3).  This showed a very significant partial rescue, up to the state
of eclosion) of the complete lethality (no first instar larvae) observed with the
overexpression of Pum in the muscles.
Overexpression of A Domain of Pumilio in Muscles Results in an Increase
of GluRIIa
In et7/et9 mutants, GluRIIa levels have been shown to increase, and eIF-
4E levels have also been shown to increase.  Pumilio binds directly to eIF-4E, a
translation factor, mRNA and represses its expression (Menon et al., 2004).
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Observed increases in GluRIIa could derive from a direct de-repression of
GluRIIa mRNA by Pum, or from the observed increase in eIF-4E because eIF-4E
is a limiting agent during translation (Sonenberg and Grings, 1998).  We wanted
to test to see if this putative loss of function phenotype could be recapitulated by
overexpressing NQ1.  Overexpression of NQ1 in muscles by crossing UAS NQ1
to 24B-GAL4 showed no significant increase in GluRIIa levels.  UAS NQ1
crossed to et9, 24B-GAL4, however, did show an increase in GluRIIa levels
comparable to that observed in in et7/et9 (Figure 3).  This implies that the
overexpression of UAS NQ1 is able to act in a manner similar to pum mutant
alleles.
Discussion
The overexpression of a domain of Pumilio that is capable of aggregating
in vivo in yeast, and recapitulating some of the “prion” phenotypes associated
with well-characterized yeast “prions,” is capable of regulating Pum-mediated
activities at the Drosophila neuromuscular junction synapse, including altering
bouton numbers and increasing levels of GluRIIa.  Interestingly, these
phenotypes are only observed under heterozygote Pum mutant alleles, putative
Pum loss of function backgrounds, which have no phenotypes on their own.  This
implies that there is some type of interaction, not necessarily direct, between
endogenous Pum and the overexpression of an aggregate-prone domain of Pum.
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It is tempting to hypothesize that the observed data might be accounted
for if the overexpression of the NQ1 region of pumilio was aggregating in vivo
and slowly seeding the aggregation of endogenous Pum, such that under
conditions where there is already a decrease of full-length Pum, phenotypes
occur that represent Pum loss of function.
No Abdominal Segmentation Phenotype Observed
The lack of any abdominal segmentation phenotype or other gross
morphological phenotype in lines that were clearly overexpressing NQ1 as
visualized through CFP expression can be explained in several ways.  This may
be because NQ1 overexpression was not capable of causing either NQ1
aggregation, or the ability of NQ1 aggregates to catalyze the aggregation of
endogenous Pum in Drosophila embryonic cells.  The lack of a phenotype could
also be attributed to sufficient levels of molecular chaperones to ensure lack of
aggregation of a Q/N rich, aggregation-prone protein at such a critical stage for
survival.  In addition, it could be that there was still sufficient endogenous Pum to
carry out hunchback repression, resulting in a normal segmentation pattern.  This
explanation makes the most sense given the larval phenotypes, and it might be a
good idea to revisit this line and look for any abdominal segmentation alterations
in an et9 heterozygote background.
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NQ1 Overexpression in the Muscles Leads to a Pum Loss of Function
Phenotype Resulting in an Increase of Type 1s and Type 1s Boutons
Specifically, type 1s boutons increase when NQ1 is overexpressed in
muscles, phenocopying the observed increase in pum mutant lines.  Given the
data that shows that this increase in 1s boutons is only rescued by expressing
full-length Pum in muscles and not in neurons, yet observed decreases in type
1b boutons in pum mutant lines are only rescued through full-length Pum
overexpression in neurons, implies that Pum possesses distinct roles
presynaptically when it comes to regulating synaptic growth (Menon et al., 2004).
The increase in type 1s boutons that were observed, therefore, may be through a
decrease in endogenous FLPum caused by the aggregation seeded by
aggregates of overexpressed NQ1 in the muscle.  This would mean that the loss
of function in this case is only on the muscle side, in contrast to the et7/et9 cross,
where there is putatively no wild type Pumilio in any tissue, except for maternal
contributions in the embryo.  Given the fact that the increase in 1s boutons in
et7/et9 is only rescued in the muscles, however, this implies that this observed
increase in 1s boutons is due to loss of function from the muscle side.  This is not
to say that loss of function of Pum at the neuronal level might also lead to an
increase in 1s, but that a loss of function, or whatever phenotype conveyed by a
lack of wild-type pum allele, on the muscle side is sufficient to cause the increase
in 1s boutons.  We do not yet know whether abnormal Pum expression on the
muscle side is necessary for an increase in 1s, but it does not seem to be the
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case from preliminary experiments which show that neuronal-only
overexpression of NQ1 leads to an increase of type 1s (Salazar, unpublished
data).  In these experiments, normal levels of Pum are expressed in the muscle
because NQ1 is driven only in the neurons.
NQ1 Overexpression in the Muscles Leads to a Pum Loss of Function
Phenotype Resulting in an Increase of Type 1b Boutons
Furthermore, it was observed that Drosophila larval NMJ type1b boutons
decreased under the different pum mutant backgrounds studied (Menon et al.,
2004).  This phenotype, however, seemed to be regulated on the neuronal side.
because this phenotype was only rescued when full-length Pum was driven in
neurons and not when Pum was driven in muscles.  This means that the
observed et7/et9 effect on 1b boutons is caused from the neuronal side of the
synapse.  At first glance, the data presented here might seem to contradict the
et7/et9 data observed by Menon, but in the case of the data presented here,
there are no large forced genetic changes at the neuronal side of the synapse
because everything is being driven in the muscle.  There is the heterozygote
effect of having et9 instead of one wild-type copy of pum on both the neuronal
and muscle side, but there are no observed changes in boutons with this line.  It
is only when NQ1 is overexpressed, in this case on the muscle side, that a
phenotype occurs.   The increase in 1b, therefore, could be explained by the
possibility that in the case where two copies of mutant pum are not present in the
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neuron, and a putative loss of function is driven only in the muscles, numbers of
type 1b boutons increase.
The observed increase in type 1b boutons also makes sense if one
considers eIF-4e data.  It has been observed by two groups that an
overexpression of eIF-4e in the muscle results in an increase in type 1b boutons
(Sigrist et al, 2000, Menon et al., 2004).  Since it has also been observed that
overexpression of Pum in the muscle can rescue this phenotype, this data
implies that muscle expression of Pum does impact levels of 1b.  Since an
increase in eIF-4e levels are observed in et7/et9 crosses, and Pum directly
represses eIF-4e levels (Menon et al., 2004), this implies that a loss of function of
Pum on the muscle side may be responsible for the increase in type 1b boutons.
Since more eIF-4e arises when there is less Pum available and more type 1b
boutons occur when there is an increase of eIF-4e, observed increases in type
1b presented here make sense if NQ1 overexpression in the muscle is causing a
decrease in Pum repression of eIF-4e.
A caveat to these hypotheses is the fact that we do not know the exact
nature of the proteins being made by these pum mutants.  For example, we know
that both et7 and et9 produce a protein, albeit more of the smaller isoform of
Pum normally observed on Western blots, but we do not yet know the exact
nature of the protein.  This is especially true considering that when using the α-
PumN antibody, a greater decrease of Pum is observed with the et7/et9 larvae
than when using the α-PumRBD antibody.  Given the locations of the EMS
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mutation, this data is slightly confusing, unless the variance is caused by
antibody quality, a reasonable possibility.  If, however, the proteins being made
are just not completely functional but still retain the various Q regions, one might
expect that these proteins may be capable of forming aggregates themselves,
although overexpression may be necessary to initiate the formation of
aggregates.  Furthermore, it could be that the putative loss of function
phenotypes are actually a gain-of-function caused by the presence of the
proteins made from these alleles.  This hypothesis, however, is not backed up by
the observation that any of these alleles over +, in other words, heterozygote
expression in the presence of one good copy of Pumilio does not show any
changes in 1b or 1s, while the Pum mutant alleles expressed as a heterozygote
over deficiency do have a phenotype.  If the observed phenotypes were due only
to a gain of function of the Pum mutant allele, this observation would not make
sense because both crosses have only one mutant allele, yet phenotypes differ
depending on whether the flies contain one other copy of pum.  The only other
explanation for this observation is that there is another gene in the various
deficiency lines used that genetically interacts with Pum, or is involved in
decreasing its ability to act in a gain of function manner.  This seems fairly
unlikely, however.  It therefore seems, from this argument as well as from
unpublished RNAi data, that the observed phenotypes are caused by a loss of
function of Pum and that loss of function in either the neuron, the muscle, or both
may result in different phenotypes.
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NQ1 Overexpression in the Muscles Leads to a Pum Loss of Function
Phenotype Resulting in an Increase of GluRIIa
GluRIIa levels are increased in a manner that is similar to et7/et9, when
one wild-type copy of pum is replaced with et9, and NQ1 is driven in the muscles.
This data can also be explained by a loss of function of Pum in muscles caused
by the overexpression of NQ1.  This also phenocopies previous data showing
that GluRIIa levels increase in a Pum loss of function background (Menon et al.
2004) because Pum may either directly regulate GluRIIa levels, or eIF-4e could
regulate GluRIIa levels.  Under conditions when there is an increase in eIF-4e, it
is hypothesized that more transcripts, possibly including GluRIIa, can be
translated because eIF-4e is one of the limiting factors for translation (Sonenberg
and Gringras, 1998).  Again, this data can be explained by the possibility that the
overexpression of NQ1 in muscles results in the aggregation of the NQ1 domain
of Pum, which then is capable of seeding the aggregation of endogenous Pum,
resulting in a loss of Pum function phenotype that causes a decrease in Pum
repression of its targets, resulting in an increase of GluRIIa.
Overexpression of Both NQ1 and FL-Pumilio in Muscles Partially Rescues
Overexpression of FL-Pumilio Lethality
Overexpression of both NQ1 and FL-Pum in muscles results in a
phenotype where the embryos not only hatch and form larvae, in contrast to
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overexpression of Pum with 24B, but they survive until the moment of eclosion,
but cannot make it out of their pupae.  This observation also implies that an
interaction exists between NQ1 and Pum, with NQ1 ameliorating the deleterious
effect of overexpressing Pum.  The exact cause of the lethality when
overexpressing Pum is not known.  Given Pum’s crucial role in early embryonic
development, however, too much Pum may result in the over-repression of
genes that are necessary for survival.
Another interesting hypothesis is that overexpressing Pum actually
initiates self-aggregation and the resulting lethality is actually caused by
aggregates of some type or the loss of function of Pum, which is believed to be
toxic.  Furthermore, overexpressing the RBD domain of Pum is capable of
rescuing early embryonic phenotypes (Barker, 1992), perhaps implying that the
RBD alone is sufficient for the translational repression activity of Pum.  Also,
overexpressing the RBD region alone may not be as lethal as overexpressing the
FL-Pum.  Even so, overexpressing the RBD region in neurons is not capable of
rescuing the same the decrease in type 1b boutons observed in et7/et9, while
overexpressing FL-Pum could rescue the phenotype (Menon et al., 2004).  This
means that the RBD is not capable of recapitulating Pum overexpression
phenotypes in neurons, implying that the N-terminal part of Pum does play a role
in the function of Pum.  This means that the differing level of lethality observed
when overexpressing either Pum or the RBD domain are most likely caused by
differences in function and not differences in the ability to aggregate.
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Furthermore, if Pum toxicity was a result of its ability to aggregate, thereby
leading to a loss of function of Pum, or leading to the toxic effects of unnatural
aggregate formation, then one might expect that NQ1 overexpression would be
even more lethal if it could further seed the aggregation of Pum.  Instead, it
partially rescues the phenotype, perhaps because it is involved in decreasing the
availability of Pum, with a normal conformation produced by the overexpression
of FL-Pum, for repression.  In other words, NQ1 decreases levels of functional
Pum to a level that is less toxic than when FL-Pum is overexpressed.  This could
imply that the overexpression of FL-Pum does not aggregate on its own and that
a seed is required for this to occur, or it could imply that the rate of FL-Pum
aggregation is much slower with being seeded by the overexpression of NQ1 and
that the embryos die prior to aggregation causing a sufficient decrease in
overexpressed FL-Pum.  Although this data does not show that NQ1 is
aggregating, or that NQ1 aggregates result in a decrease of FL-Pum in its natural
conformation, and, therefore, a decrease in the abnormal repression possibly
caused by overexpressing FLPum, the data does show that an interaction
between Pum and NQ1 is occurring.  It is not necessarily direct, however.
The original purpose of this project was to attempt to discover a conserved
protein found in both Drosophila and C. elegans, and, hopefully, higher
organisms that could act like a genetic switch.  We have shown that Pumilio is
capable of aggregating in yeast prion assays and can induce the formation of the
aggregated state of Sup35 to the same degree as the New1PrD yeast prion in
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the assays.  In addition, the overexpression of a domain of Pum has been shown
to phenocopy muscle loss of function of Pum in an et9 background.  This is
observed through an increase in type 1s and type 1b boutons at the larval NMJ,
as well as an increase in GluRIIa expression at the NMJ.  In addition, the
aggregation-prone domain of Pum has been shown to rescue the embryonic
lethality caused by overexpression of Pum in the muscles.  This data shows that
there is a genetic interaction between endogenous Pum and the overexpressed
NQ1 domain.  This could imply an epigenetic activity if this observed interaction
is caused only through the overexpression of NQ1.  Whether the observed data
corresponds to a direct interaction and aggregation in vivo in Drosophila, is yet to
be determined.  In addition, even if this domain does cause the aggregation of
endogenous Pum, and, hence, the loss of function phenotypes observed in this
study, we have yet to address whether Pum actually makes use of this ability to
form aggregates normally.  Even if Pum does not make use of this ability to form
ordered aggregates in order to carry out its function, it is intriguing to hypothesize
that other proteins that aggregate and cause diseases, such as Aβ, may either
seed the abnormal aggregation of Pum or of other proteins located at the
synapse that possess either Q/N rich regions or a proclivity to form aggregates;
this might be responsible for the observed toxicity associated with Aβ42
oliogmers in cultured cells and in vivo in the rat.  Neurotoxic aggregates do not
even have to actually seed the aggregation of other proteins.  These toxic Aβ
oligomers might, instead, just bind to these Q/N rich regions and perturb normal
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function.  Whether endogenous Pum turns out to make use of an epigenetic
switch in order to mark synapses for long term memory perhaps through directly
increasing GluRIIa expression therefore, is not the only intriguing scientific
question to come out of this work, but also whether Pum and other putative
aggregate prone proteins located at the synapse might play a role in Aβ42
toxicity.  In addition, this work might not just be important in the study of
Alzheimer’s Disease, but it may be able to spread light on neurodegenerative
disorders that involve protein aggregation in general, by providing a possible
model system for the screening for modifiers of some of the phenotypes
observed with the overexpression of NQ1.
Experimental Procedures
Genetics
Wild-type controls were created when w1118 was crossed to UAS-NQ1,
UAS-ΔNQ1, 24B, et9,24B/TM6B or msc,24B/TM6B, depending on the
experiment.  In addition, GMR-Gal4 was crossed to w118 as a control for rough
eye phenotypes.  UAS-NQ1 (from pUASP), UAS-NQ1 (from pUAST), and UAS-
ΔNQ1 were created by standard techniques.  Maternal drivers were obtained
from Bloomington Stock Center. UAS-NQ1 was recombined with both UAS-pum-
pum 3’utr and UAS-pum-tubulin 3’utr.  Most crosses were conducted at 29°C,
except for et7/et9 because GAL4 expression is strongest at 29°C, but et7/et9
defects are strongest at 18°C.  UAS-NQ1 crosses to maternal drivers were first
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conducted at 3 temperatures, 18°C, 25°C, and 29°C to determine which
temperature might show the strongest phenotypes.  Subsequent crosses were
conducted at 29°C.
Cuticle preparations
Cuticle preparations were conducted by standard procedures.  Embryos
were grown until full development, then removed from the chorions and
membranes and mounted under coverslips in a mixture of lactic acid/Hoyer’s
medium and incubated overnight at 60°C.  These slides were then analyzed by
microscopy.
Antibodies and Imunocytochemistry
The following antibodies were used in these experiments: rat anti-Pum
RBD (Sonada and Wharton, 1999), mouse anti-Dlg (from Corey Goodman),
mouse anti-GluRIIa (from Developmental Studies Hybridoma Bank), and TRITC
conjugated HRP (from Jackson Labs).  Secondary antibodies used were: Alexa
Fluor 488 anti-mouse (from molecular Probes) and Alexa Fluor 568 anti-rat (from
Molecular Probes).
Third instar larvae were dissected in PBS and fixed in 4%
paraformaldehyde or Bouin’s fix (Sigma).
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Confocal Microscopy
The Zeiss LSM 510 inverted microscope was used for the creation of final
images. Appropriate lasers were used to excite the fluorescently tagged
antibodies at either 488 or 568.  A 63x oil immersion objective was used, and
projected z-stacks with intervals of .5 µm were obtained for final images.   Muscle
4 from the second and third segments of each larva was imaged and counted,
resulting in four hemi-segments per larva.
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Figure Legends
Figure 1a. Drosophila NMJ boutons on muscle 4 of the second or third
abdominal segments of third instar larvae. Different UAS-NQ1 lines were crossed
to 24B-GAL4 and grown at 29°C. Live third instar larvae were dissected, fixed for
20 minutes and stained with anti-dlg (green), a post-synaptic marker, and TRITC-
conjugated anti-HRP (red), a neuronal marker.  (A-I) Control lines containing
w1118/24B-GAL4 and w118/+; ET9, 24B/+.  They have fewer type 1s boutons
(arrowhead) and sometimes 0 type 1s boutons (See D-I).  They also have fewer
type 1b boutons (arrows).  (J-L)  UAS-NQ1/+; ET9, 24B/+.  A dramatic increase
in both type 1s (arrowheads) and type 1b (arrows) is observed.
Figure 1b.  (A-C) A different UAS NQ1 line than the one shown in Figure 1a, but
containing the same drivers and background: UAS-NQ1/+; ET9, 24B/+.  (D-I)
Two different lines of delta-NQ1: UAS-NQ1/+; et9, 24B/+.  No type 1s boutons
(arrowheads) are observed in these segments and few type 1b (arrows).  (J-L) A
higher magnification view of the same NMJ in (J-L) from Figure 1a.
Figure 2a. Type 1s Bouton Counts are shown. The bars correspond to the
average number of boutons per hemi-segment. Only muscle 4 from segments 2
and 3 were used.  Error bars show standard error.  The only significant difference
between amounts of 1s boutons and the control are for the two tallest bars, which
are highly significant with p-values < .0001 (student’s t test).  Those bars
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correspond to UAS-NQ1/+; et9,24B-GAL4/+.  The genotypes and n are as
follows: UAS-NQ1/w1118 (n=9), w1118/24B-GAL4 (n=34), UAS-NQ1/24B-GAL4
(n=13), UAS-NQ1/24B-GAL4 (n=9), UAS-deltaNQ1/24B-GAL4 (n=24), UAS-
deltaNQ1/24B-GAL4 (n=16), w1118/+; et9, 24B-GAL4/+ (n=34), UAS-NQ1/+;
et9,24B-GAL4/+ (n=39), UAS-NQ1/+; et9,24B-GAL4/+ (n=15), UAS-deltaNQ1/+;
et9,24B-GAL4/+ (n=17).
Figure 2b. Type 1b Bouton Counts are shown.  The bars correspond to the
average number of boutons per hemi-segment. Only muscle 4 from segments 2
and 3 were used.  Error bars show standard error.  The only significant difference
between amounts of type1b boutons and the control are for the two tallest bars,
which are highly significant with p-values < .0001 (student’s t-test).  Those bars
correspond to UAS-NQ1/+; et9,24B-GAL4/+.  The genotypes and n are as
follows: UAS-NQ1/w1118 (n=9), w1118/24B-GAL4 (n=34), UAS-NQ1/24B-GAL4
(n=13), UAS-NQ1/24B-GAL4 (n=9), UAS-deltaNQ1/24B-GAL4 (n=24), UAS-
deltaNQ1/24B-GAL4 (n=16), w1118/+; et9, 24B-GAL4/+ (n=34), UAS-NQ1/+;
et9,24B-GAL4/+ (n=39), UAS-NQ1/+; et9,24B-GAL4/+ (n=15), UAS-deltaNQ1/+;
et9,24B-GAL4/+ (n=17).
Figure 3. (A)  Average number of Drosophila that survive until the pupal stage
after 24 hour embryo collections.  Different recombinant lines and balanced lines
that drive the overexpression of NQ1 in the muscle were analyzed for their ability
to rescue embryonic lethality caused by the overexpression of Pum in the
89
muscles.  Two different UAS-Pum lines were used, one that contained the 3’utr
of Pum and one that contained the 3’utr of Tubulin, which is a stronger line.  The
Pum 3’utr line has escapers when grown at 18 or 25 degrees, while the Tub 3’utr
line does not.   A dramatic rescue was observed, from 0 larvae and pupae in the
UAS-Pum crosses, to at least 15 per vial per 24 hour collection, comparable to
w1118/24B.  8 one-week-old virgin 24B-GAL4 females were crossed to 5 males
and allowed to grow for 28 hours on green vial food prior to initiating the
collection period.  The embryos were collected by transferring the adults to new
vials and keeping the vials at 29 degrees for 9 days to analyze the phenotype.
Lines were transferred over 10 consecutive days at noon.  The following lines
were used:  UAS-NQ1/+; UAS-Pum-Pum3'utr/24B-GAL4, UAS-NQ1,UAS-
Pum.Pum3'utr/24B-GAL4, UAS-NQ1,UAS-Pum-Tub3'utr/24B-GAL4, UAS-
NQ1,UAS-Pum-Tub3'utr/24B-GAL4, UAS-Pum-Pum3'utr/24B-GAL4, UAS-Pum-
Tub3'utr/24B-GAL4, w1118/24B-GAL4.   No larvae were consistently found alive
in the numerous crosses made with UAS-Pum and 24B-GAL4 when this cross
was grown at 29°C.
(B)  Percent of Drosophila that did not eclose from their pupae. A partial rescue
was observed when NQ1 was overexpressed at the same time as UAS-Pum in
muscles.  Numbers of larvae were almost comparable to the w1118/24B-GAL4
control.  Virtually none of these larvae, however, were able to fully develop into
adult flies and eclose from their pupae.  It did appear that the flies fully form, but
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that they could not climb out of their pupae.  Many of progeny of this cross could
not fully emerge from their pupal cases and died, resulting in a large number of
partially eclosed flies.  This lack of pupal emergence phenotype was highly
significant with p-values << .0001 (student’s t-test).  Error bars are above the
data in the table.  Data for the UAS-Pum lines crossed to 24B is not shown
because 0 larvae and therefore 0 pupae existed.  This phenotype was almost
100% penetrant in all lines analyzed.
Figure 4.  GluRIIa expression is increased in a manner similar to et7/et9.
Control lines used in this experiment include w1118/24BGAL4 or w1118/+;
et9,24B/+.  No significant increase in GluRIIa staining was observed in either of
these lines.  Panels (A-C) show the anti-GluRIIa staining (green), anti-HRP
staining (red), and merge of one of the controls.  Lines were grown at 29°C.
Panels (D-F) show an increase above wild-type of GluRIIa staining in crosses
overexpressing NQ1: UAS-NQ1/+; et9,24B-GAL4/+ . (G-I) et7/et9 was used as a
positive control.
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Figure 1a. NMJ Boutons
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Figure 1b.  NMJ boutons
93
Figure 2a.  Type 1s Bouton Counts
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Figure 2b.  Type 1b Bouton Counts
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Figure 3.  (A) Total Number of Pupae After 24 hours in a Vial
                 (B) Percent of Flies That Do Not Eclose
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Figure 4. GluRIIa expression is increased in a manner similar to et7/et9
97
References
Barker, D. D., Wang, C., Moore, J., Dickinson, L. K. and Lehmann, R., 1992.
Pumilio is essential for function but not for distribution of the Drosophila
abdominal determinant Nanos. Genes Dev. 6, 2312-2326.
Dubnau, J., Chiang, A. S., Grady, L., Barditch, J., Gossweiler, S., McNeil, J.,
Smith, P., Buldoc, F., Scott, R., Certa, U., Broger, C. and Tully, T., 2003a.
The staufen/pumilio pathway is involved in Drosophila long-term memory.
Curr Biol. 13, 286-296.
Dubnau, J., Chiang, A. S. and Tully, T., 2003b. Neural substrates of memory:
from synapse to system. J Neurobiol. 54, 238-253.
Eaton, B. A. and Davis, G. W., 2003. Synapse disassembly. Genes Dev. 17,
2075-2082.
Edwards, T. A., Pyle, S. E., Wharton, R. P. and Aggarwal, A. K., 2001. Structure
of Pumilio reveals similarity between RNA and peptide binding motifs.
Cell. 105, 281-289.
Ellis, M. C., O'Neill, E. M. and Rubin, G. M., 1993. Expression of Drosophila
glass protein and evidence for negative regulation of its activity in non-
neuronal cells by another DNA-binding protein. Development. 119, 855-
865.
98
Forbes, A. and Lehmann, R., 1998. Nanos and Pumilio have critical roles in the
development and function of Drosophila germline stem cells.
Development. 125, 679-690.
Gavis, E. R. and Lehmann, R., 1994. Translational regulation of nanos by RNA
localization. Nature. 369, 315-318.
Keshishian, H., Broadie, K., Chiba, A. and Bate, M., 1996. The drosophila
neuromuscular junction: a model system for studying synaptic
development and function. Annu Rev Neurosci. 19, 545-575.
Kraut, R., Menon, K. and Zinn, K., 2001. A gain-of-function screen for genes
controlling motor axon guidance and synaptogenesis in Drosophila. Curr
Biol. 11, 417-430.
Lee, T., Lee, A. and Luo, L., 1999. Development of the Drosophila mushroom
bodies: sequential generation of three distinct types of neurons from a
neuroblast. Development. 126, 4065-4076.
Lehmann, R. and Nusslein-Volhard, C., 1991. The maternal gene nanos has a
central role in posterior pattern formation of the Drosophila embryo.
Development. 112, 679-691.
Macdonald, P. M., 1992. The Drosophila pumilio gene: an unusually long
transcription unit and an unusual protein. Development. 114, 221-232.
Martin, K. C. and Zukin, R. S., 2006. RNA Trafficking and Local Protein
99
Synthesis in Dendrites: An Overview. J Neurosci %R
101523/JNEUROSCI1801-062006. 26, 7131-7134.
Menon, K. P., Sanyal, S., Habara, Y., Sanchez, R., Wharton, R. P., Ramaswami,
M. and Zinn, K., 2004. The translational repressor Pumilio regulates
presynaptic morphology and controls postsynaptic accumulation of
translation factor eIF-4E. Neuron. 44, 663-676.
Parisi, M. and Lin, H., 1999. The Drosophila pumilio gene encodes two functional
protein isoforms that play multiple roles in germline development,
gonadogenesis, oogenesis and embryogenesis. Genetics. 153, 235-250.
Purves, D. and Lichtman, J. W., 1980. Elimination of synapses in the developing
nervous system. Science %R 101126/science7414326. 210, 153-157.
Reiter, L. T., Potocki, L., Chien, S., Gribskov, M. and Bier, E., 2001. A systematic
analysis of human disease-associated gene sequences in Drosophila
melanogaster. Genome Res. 11, 1114-1125.
Rorth, P., 1998. Gal4 in the Drosophila female germline. Mech Dev. 78, 113-118.
Rorth, P., Szabo, K., Bailey, A., Laverty, T., Rehm, J., Rubin, G. M., Weigmann,
K., Milan, M., Benes, V., Ansorge, W. and Cohen, S. M., 1998. Systematic
gain-of-function genetics in Drosophila. Development. 125, 1049-1057.
Rubin, G. M., Yandell, M. D., Wortman, J. R., Gabor Miklos, G. L., Nelson, C. R.,
Hariharan, I. K., Fortini, M. E., Li, P. W., Apweiler, R., Fleischmann, W.,
100
Cherry, J. M., Henikoff, S., Skupski, M. P., Misra, S., Ashburner, M.,
Birney, E., Boguski, M. S., Brody, T., Brokstein, P., Celniker, S. E.,
Chervitz, S. A., Coates, D., Cravchik, A., Gabrielian, A., Galle, R. F.,
Gelbart, W. M., George, R. A., Goldstein, L. S., Gong, F., Guan, P., Harris,
N. L., Hay, B. A., Hoskins, R. A., Li, J., Li, Z., Hynes, R. O., Jones, S. J.,
Kuehl, P. M., Lemaitre, B., Littleton, J. T., Morrison, D. K., Mungall, C.,
O'Farrell, P. H., Pickeral, O. K., Shue, C., Vosshall, L. B., Zhang, J., Zhao,
Q., Zheng, X. H. and Lewis, S., 2000. Comparative genomics of the
eukaryotes. Science. 287, 2204-2215.
Schuman, E. M., Dynes, J. L. and Steward, O., 2006. Synaptic Regulation of
Translation of Dendritic mRNAs. J Neurosci %R
101523/JNEUROSCI1796-062006. 26, 7143-7146.
Schweers, B. A., Walters, K. J. and Stern, M., 2002. The Drosophila
melanogaster translational repressor pumilio regulates neuronal
excitability. Genetics. 161, 1177-1185.
Si, K., Giustetto, M., Etkin, A., Hsu, R., Janisiewicz, A. M., Miniaci, M. C., Kim, J.
H., Zhu, H. and Kandel, E. R., 2003a. A neuronal isoform of CPEB
regulates local protein synthesis and stabilizes synapse-specific long-term
facilitation in aplysia. Cell. 115, 893-904.
Si, K., Lindquist, S. and Kandel, E. R., 2003b. A neuronal isoform of the aplysia
CPEB has prion-like properties. Cell. 115, 879-891.
101
Sonoda, J. and Wharton, R. P., 1999. Recruitment of Nanos to hunchback
mRNA by Pumilio. Genes Dev. 13, 2704-2712.
Sonoda, J. and Wharton, R. P., 2001. Drosophila Brain Tumor is a translational
repressor. Genes Dev. 15, 762-773.
Steward, O. and Levy, W. B., 1982. Preferential localization of polyribosomes
under the base of dendritic spines in granule cells of the dentate gyrus. J
Neurosci. 2, 284-291.
Sutton, M. A., Ito, H. T., Cressy, P., Kempf, C., Woo, J. C. and Schuman, E. M.,
2006. Miniature neurotransmission stabilizes synaptic function via tonic
suppression of local dendritic protein synthesis. Cell. 125, 785-799.
Sutton, M. A., Wall, N. R., Aakalu, G. N. and Schuman, E. M., 2004. Regulation
of Dendritic Protein Synthesis by Miniature Synaptic Events. Science %R
101126/science1096202. 304, 1979-1983.
Vessey, J. P., Vaccani, A., Xie, Y., Dahm, R., Karra, D., Kiebler, M. A. and
Macchi, P., 2006. Dendritic Localization of the Translational Repressor
Pumilio 2 and Its Contribution to Dendritic Stress Granules. J Neurosci
%R 101523/JNEUROSCI0649-062006. 26, 6496-6508.
Wharton, R. P., Sonoda, J., Lee, T., Patterson, M. and Murata, Y., 1998. The
Pumilio RNA-binding domain is also a translational regulator. Mol Cell. 1,
863-872.
102
Ye, B., Petritsch, C., Clark, I. E., Gavis, E. R., Jan, L. Y. and Jan, Y. N., 2004.
Nanos and Pumilio are essential for dendrite morphogenesis in Drosophila
peripheral neurons. Curr Biol. 14, 314-321.
Zamore, P. D., Bartel, D. P., Lehmann, R. and Williamson, J. R., 1999. The
PUMILIO-RNA interaction: a single RNA-binding domain monomer
recognizes a bipartite target sequence. Biochemistry. 38, 596-604.
